EP1687326A2 - Method for obtaining natural products from plant material - Google Patents
Method for obtaining natural products from plant materialInfo
- Publication number
- EP1687326A2 EP1687326A2 EP04811101A EP04811101A EP1687326A2 EP 1687326 A2 EP1687326 A2 EP 1687326A2 EP 04811101 A EP04811101 A EP 04811101A EP 04811101 A EP04811101 A EP 04811101A EP 1687326 A2 EP1687326 A2 EP 1687326A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- mixture
- water
- solvent
- solids
- betulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 171
- 229930014626 natural product Natural products 0.000 title claims abstract description 28
- 239000000463 material Substances 0.000 title claims description 29
- 239000000203 mixture Substances 0.000 claims abstract description 224
- 235000018185 Betula X alpestris Nutrition 0.000 claims abstract description 125
- 235000018212 Betula X uliginosa Nutrition 0.000 claims abstract description 125
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 105
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 claims abstract description 73
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 claims abstract description 73
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 claims abstract description 73
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 claims abstract description 73
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 claims abstract description 73
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 claims abstract description 73
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 claims abstract description 71
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 claims abstract description 70
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 claims abstract description 70
- 239000000284 extract Substances 0.000 claims abstract description 70
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 claims abstract description 49
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 claims abstract description 49
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000009835 boiling Methods 0.000 claims abstract description 27
- 241000196324 Embryophyta Species 0.000 claims description 84
- 239000002904 solvent Substances 0.000 claims description 67
- 239000007787 solid Substances 0.000 claims description 65
- 239000008096 xylene Substances 0.000 claims description 55
- 150000003738 xylenes Chemical class 0.000 claims description 39
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- 150000001875 compounds Chemical class 0.000 claims description 34
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 33
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 24
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 22
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 20
- 238000005406 washing Methods 0.000 claims description 16
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- 239000003495 polar organic solvent Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 13
- 230000001376 precipitating effect Effects 0.000 claims description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 claims description 12
- 239000011230 binding agent Substances 0.000 claims description 12
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 11
- 235000009113 Betula papyrifera Nutrition 0.000 claims description 9
- 239000012452 mother liquor Substances 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 8
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 claims description 7
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 7
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 7
- 241000219430 Betula pendula Species 0.000 claims description 6
- 235000009109 Betula pendula Nutrition 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229910000103 lithium hydride Inorganic materials 0.000 claims description 6
- 230000003472 neutralizing effect Effects 0.000 claims description 6
- 239000008188 pellet Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 6
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- 240000003604 Dillenia indica Species 0.000 claims description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 240000000315 Tetracera scandens Species 0.000 claims description 4
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910001416 lithium ion Inorganic materials 0.000 claims description 4
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052987 metal hydride Inorganic materials 0.000 claims description 4
- 150000004681 metal hydrides Chemical class 0.000 claims description 4
- 229910001415 sodium ion Inorganic materials 0.000 claims description 4
- 244000274847 Betula papyrifera Species 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- 229940078552 o-xylene Drugs 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 3
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- UAEJRRZPRZCUBE-UHFFFAOYSA-N trimethoxyalumane Chemical compound [Al+3].[O-]C.[O-]C.[O-]C UAEJRRZPRZCUBE-UHFFFAOYSA-N 0.000 claims description 3
- MDDPTCUZZASZIQ-UHFFFAOYSA-N tris[(2-methylpropan-2-yl)oxy]alumane Chemical compound [Al+3].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] MDDPTCUZZASZIQ-UHFFFAOYSA-N 0.000 claims description 3
- 241001457438 Acrotrema Species 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 235000006526 Dillenia Nutrition 0.000 claims description 2
- 235000006528 Dillenia indica Nutrition 0.000 claims description 2
- 241001648289 Dillenia retusa Species 0.000 claims description 2
- 244000064554 Diospyros aurea Species 0.000 claims description 2
- 244000149363 Dissochaeta bracteata Species 0.000 claims description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 2
- 241001671201 Tetracera Species 0.000 claims description 2
- 244000041473 Tetracera akara Species 0.000 claims description 2
- 240000003892 Tetracera indica Species 0.000 claims description 2
- 241000590110 Uapaca nitida Species 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000011260 aqueous acid Substances 0.000 claims description 2
- 229910001422 barium ion Inorganic materials 0.000 claims description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 2
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 claims description 2
- 229940008406 diethyl sulfate Drugs 0.000 claims description 2
- MFOMDTCBCZQHQZ-UHFFFAOYSA-N ethoxymethanetriol Chemical compound CCOC(O)(O)O MFOMDTCBCZQHQZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001475 halogen functional group Chemical group 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 150000002905 orthoesters Chemical class 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims 2
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 claims 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 claims 1
- 229910018624 Al(OPr)3 Inorganic materials 0.000 claims 1
- 240000002999 Bacopa monnieri Species 0.000 claims 1
- 235000015418 Bacopa monnieria Nutrition 0.000 claims 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 claims 1
- 125000005210 alkyl ammonium group Chemical group 0.000 claims 1
- JPUHCPXFQIXLMW-UHFFFAOYSA-N aluminium triethoxide Chemical compound CCO[Al](OCC)OCC JPUHCPXFQIXLMW-UHFFFAOYSA-N 0.000 claims 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- WOZZOSDBXABUFO-UHFFFAOYSA-N tri(butan-2-yloxy)alumane Chemical compound [Al+3].CCC(C)[O-].CCC(C)[O-].CCC(C)[O-] WOZZOSDBXABUFO-UHFFFAOYSA-N 0.000 claims 1
- 125000004385 trihaloalkyl group Chemical group 0.000 claims 1
- OBROYCQXICMORW-UHFFFAOYSA-N tripropoxyalumane Chemical compound [Al+3].CCC[O-].CCC[O-].CCC[O-] OBROYCQXICMORW-UHFFFAOYSA-N 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 abstract description 19
- 238000004821 distillation Methods 0.000 abstract description 15
- 239000000419 plant extract Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 50
- 150000007513 acids Chemical class 0.000 description 45
- 230000008569 process Effects 0.000 description 39
- 150000003648 triterpenes Chemical class 0.000 description 36
- 210000001519 tissue Anatomy 0.000 description 27
- 239000007788 liquid Substances 0.000 description 25
- 229920001864 tannin Polymers 0.000 description 19
- 235000018553 tannin Nutrition 0.000 description 19
- 239000001648 tannin Substances 0.000 description 19
- 239000002585 base Substances 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 239000000706 filtrate Substances 0.000 description 17
- 150000004665 fatty acids Chemical class 0.000 description 16
- 230000002378 acidificating effect Effects 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 150000004692 metal hydroxides Chemical class 0.000 description 13
- 244000100792 paper birch Species 0.000 description 13
- 241001520764 Betula pubescens Species 0.000 description 12
- 230000007062 hydrolysis Effects 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 12
- 244000194101 Ginkgo biloba Species 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 240000002234 Allium sativum Species 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 10
- 244000126014 Valeriana officinalis Species 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 10
- 235000004611 garlic Nutrition 0.000 description 10
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 10
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 9
- 235000008100 Ginkgo biloba Nutrition 0.000 description 9
- 240000004371 Panax ginseng Species 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 238000010533 azeotropic distillation Methods 0.000 description 9
- 239000000470 constituent Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- 244000228088 Cola acuminata Species 0.000 description 8
- 235000010205 Cola acuminata Nutrition 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 240000005546 Piper methysticum Species 0.000 description 8
- 235000016787 Piper methysticum Nutrition 0.000 description 8
- 235000013832 Valeriana officinalis Nutrition 0.000 description 8
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 8
- 150000002215 flavonoids Chemical class 0.000 description 8
- 235000017173 flavonoids Nutrition 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 229910000000 metal hydroxide Inorganic materials 0.000 description 8
- 235000016788 valerian Nutrition 0.000 description 8
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 8
- 235000003932 Betula Nutrition 0.000 description 7
- 241000219429 Betula Species 0.000 description 7
- 244000089654 Betula populifolia Species 0.000 description 7
- 235000011201 Ginkgo Nutrition 0.000 description 7
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 7
- 229930012538 Paclitaxel Natural products 0.000 description 7
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- 229960001592 paclitaxel Drugs 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 7
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 6
- 244000189108 Betula alleghaniensis Species 0.000 description 6
- 241001537740 Betula maximowicziana Species 0.000 description 6
- 241001606223 Betula nana Species 0.000 description 6
- 244000276440 Betula nigra Species 0.000 description 6
- 235000010928 Betula populifolia Nutrition 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000002789 Panax ginseng Nutrition 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000011399 aloe vera Nutrition 0.000 description 6
- 239000001264 anethum graveolens Substances 0.000 description 6
- 235000004883 caffeic acid Nutrition 0.000 description 6
- 229940074360 caffeic acid Drugs 0.000 description 6
- SQOJOAFXDQDRGF-WJHVHIKBSA-N ginkgolide B Natural products O=C1[C@@H](C)[C@@]2(O)[C@@H]([C@H](O)[C@]34[C@@H]5OC(=O)[C@]23O[C@H]2OC(=O)[C@H](O)[C@@]42[C@H](C(C)(C)C)C5)O1 SQOJOAFXDQDRGF-WJHVHIKBSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000012265 solid product Substances 0.000 description 6
- VOQSZICWRNPAMF-IYAXTLCYSA-N 3-(Z)-caffeoyllupeol Natural products CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)C=Cc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12 VOQSZICWRNPAMF-IYAXTLCYSA-N 0.000 description 5
- VOQSZICWRNPAMF-UHFFFAOYSA-N 3beta-E-caffeoylbetulin Natural products C12C(C(=C)C)CCC2(CO)CCC(C2(CCC3C4(C)C)C)(C)C1CCC2C3(C)CCC4OC(=O)C=CC1=CC=C(O)C(O)=C1 VOQSZICWRNPAMF-UHFFFAOYSA-N 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 241001116389 Aloe Species 0.000 description 5
- 235000002992 Betula pubescens Nutrition 0.000 description 5
- 238000006027 Birch reduction reaction Methods 0.000 description 5
- 241001632410 Eleutherococcus senticosus Species 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 5
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 241001116500 Taxus Species 0.000 description 5
- VOQSZICWRNPAMF-IUGYEWCASA-N [(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl] (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@]1(CO)CC[C@H]([C@H]41)C(=C)C)C(=O)\C=C\C1=CC=C(O)C(O)=C1 VOQSZICWRNPAMF-IUGYEWCASA-N 0.000 description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 5
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000005875 quercetin Nutrition 0.000 description 5
- 229960001285 quercetin Drugs 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 4
- 239000005711 Benzoic acid Substances 0.000 description 4
- 240000001746 Betula lenta Species 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- 235000021513 Cinchona Nutrition 0.000 description 4
- 241000157855 Cinchona Species 0.000 description 4
- 235000015438 Cola nitida Nutrition 0.000 description 4
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 4
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 4
- FFDULTAFAQRACT-OVUSVGQASA-N Eleutheroside D Chemical compound COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-OVUSVGQASA-N 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 240000001717 Vaccinium macrocarpon Species 0.000 description 4
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000004634 cranberry Nutrition 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000014134 echinacea Nutrition 0.000 description 4
- 235000020694 echinacea extract Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 235000008777 kaempferol Nutrition 0.000 description 4
- 229920005610 lignin Polymers 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- 240000000662 Anethum graveolens Species 0.000 description 3
- 235000010910 Betula neoalaskana Nutrition 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 244000133098 Echinacea angustifolia Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 244000184734 Pyrus japonica Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 241001661641 Verrucosa Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 3
- 150000004056 anthraquinones Chemical class 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000008769 eleutheroside Substances 0.000 description 3
- 229930190029 eleutheroside Natural products 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- FPUXKXIZEIDQKW-MFJLLLFKSA-N ginkgolide A Natural products O=C1[C@H](C)[C@@]2(O)[C@@H](O1)C[C@]13[C@@H]4OC(=O)[C@]21O[C@@H]1OC(=O)[C@H](O)[C@]31[C@@H](C(C)(C)C)C4 FPUXKXIZEIDQKW-MFJLLLFKSA-N 0.000 description 3
- FPUXKXIZEIDQKW-VKMVSBOZSA-N ginkgolide-a Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13C[C@@H]1OC(=O)[C@@H](C)[C@]21O FPUXKXIZEIDQKW-VKMVSBOZSA-N 0.000 description 3
- SQOJOAFXDQDRGF-MMQTXUMRSA-N ginkgolide-b Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13[C@@H](O)[C@@H]1OC(=O)[C@@H](C)[C@]21O SQOJOAFXDQDRGF-MMQTXUMRSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000001856 mountain paper birch Nutrition 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 235000001842 paper birch Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 3
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- WYUFTYLVLQZQNH-HNEXDWKRSA-N (2s,3r,4s,5r,6r)-2-ethoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O WYUFTYLVLQZQNH-HNEXDWKRSA-N 0.000 description 2
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 2
- RIXNFYQZWDGQAE-DFHVBEEKSA-N (4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-acetyloxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C([C@H]1C2=CC[C@H]34)C(C)(C)CC[C@]1(C(O)=O)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C RIXNFYQZWDGQAE-DFHVBEEKSA-N 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 2
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000018199 Betula alleghaniensis var. alleghaniensis Nutrition 0.000 description 2
- 235000018198 Betula alleghaniensis var. macrolepis Nutrition 0.000 description 2
- 235000017428 Betula maximowicziana Nutrition 0.000 description 2
- 235000009131 Betula nigra Nutrition 0.000 description 2
- 235000018720 Betula occidentalis Nutrition 0.000 description 2
- 241001313086 Betula platyphylla Species 0.000 description 2
- 235000001553 Betula platyphylla Nutrition 0.000 description 2
- 241000219495 Betulaceae Species 0.000 description 2
- IWEIJEPIYMAGTH-UHFFFAOYSA-N Bilobetin Chemical compound COC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 IWEIJEPIYMAGTH-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000218631 Coniferophyta Species 0.000 description 2
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 2
- FFDULTAFAQRACT-JSGUJALWSA-N Eleutheroside E Chemical compound COC1=CC([C@@H]2[C@@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-JSGUJALWSA-N 0.000 description 2
- FFDULTAFAQRACT-MWBGVTEFSA-N Eleutheroside E Natural products COc1cc(cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]3OC[C@H]4[C@H]3CO[C@@H]4c5cc(OC)c(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(OC)c5 FFDULTAFAQRACT-MWBGVTEFSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 241000219427 Fagales Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- AMOGMTLMADGEOQ-FNZROXQESA-N Ginkgolide C Chemical compound O([C@H]1O2)C(=O)[C@H](O)C31[C@]14[C@@H](O)[C@@H]5OC(=O)[C@@H](C)[C@]5(O)[C@@]12C(=O)O[C@@H]4[C@@H](O)[C@H]3C(C)(C)C AMOGMTLMADGEOQ-FNZROXQESA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001991 Proanthocyanidin Polymers 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000219100 Rhamnaceae Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241001116498 Taxus baccata Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 241000792914 Valeriana Species 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 240000000038 Ziziphus mauritiana Species 0.000 description 2
- 244000063792 Ziziphus mucronata Species 0.000 description 2
- 241000079527 Ziziphus spina-christi Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000004703 alkoxides Chemical class 0.000 description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010081 allicin Nutrition 0.000 description 2
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- MHAVMNJPXLZEIG-UHFFFAOYSA-N betulinic aldehyde Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C=O)CCC(C(=C)C)C5C4CCC3C21C MHAVMNJPXLZEIG-UHFFFAOYSA-N 0.000 description 2
- 239000012496 blank sample Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 235000006193 cichoric acid Nutrition 0.000 description 2
- 229930016920 cichoric acid Natural products 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 2
- COVFEVWNJUOYRL-UHFFFAOYSA-N digallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 COVFEVWNJUOYRL-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- ZKNVDVVWFWMIOY-IVCZRNNFSA-N eleutheroside A Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CC)[C@@H](O)[C@H](O)[C@H]5O)C(C)C ZKNVDVVWFWMIOY-IVCZRNNFSA-N 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 229930184727 ginkgolide Natural products 0.000 description 2
- AMOGMTLMADGEOQ-DPFZUGDXSA-N ginkgolide C Natural products O=C1[C@@H](C)[C@]2(O)[C@H]([C@H](O)[C@@]34[C@H]5[C@H](O)[C@@H](C(C)(C)C)[C@]63[C@H](O)C(=O)O[C@H]6O[C@@]24C(=O)O5)O1 AMOGMTLMADGEOQ-DPFZUGDXSA-N 0.000 description 2
- LMEHVEUFNRJAAV-HOSIAMDISA-N ginkgolide J Natural products O=C1[C@H](C)[C@@]2(O)[C@H](O1)C[C@@]13[C@H]4[C@@H](O)[C@@H](C(C)(C)C)[C@@]51[C@@H](O)C(=O)O[C@@H]5O[C@@]23C(=O)O4 LMEHVEUFNRJAAV-HOSIAMDISA-N 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 2
- 150000002559 kavalactones Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- XIJDBHLQUYAZJI-UHFFFAOYSA-N norsolorinic acid Chemical compound OC1=CC(O)=C2C(=O)C3=C(O)C(C(=O)CCCCC)=C(O)C=C3C(=O)C2=C1 XIJDBHLQUYAZJI-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 2
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 2
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 229960005137 succinic acid Drugs 0.000 description 2
- 235000011044 succinic acid Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- NUMQCACRALPSHD-UHFFFAOYSA-N tert-butyl ethyl ether Chemical compound CCOC(C)(C)C NUMQCACRALPSHD-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000083 urinary anti-infective agent Substances 0.000 description 2
- FEBNTWHYQKGEIQ-SUKRRCERSA-N valerenic acid Chemical compound C[C@@H]1CC[C@@H](\C=C(/C)C(O)=O)C2=C(C)CC[C@H]12 FEBNTWHYQKGEIQ-SUKRRCERSA-N 0.000 description 2
- FUHPCDQQVWLRRY-UHFFFAOYSA-N valerenic acid Natural products CC1CCC(C=C(/C)C(=O)O)C2C1CC=C2C FUHPCDQQVWLRRY-UHFFFAOYSA-N 0.000 description 2
- 229940038779 valerian root extract Drugs 0.000 description 2
- 239000001192 valeriana officinalis l. rhizome/root Substances 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- QWVUOVZJBNQSNS-UHFFFAOYSA-N (+-)-Tropan-3endo,6exo-diol Natural products C1C(O)CC2C(O)CC1N2C QWVUOVZJBNQSNS-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- MHAVMNJPXLZEIG-CNRMHUMKSA-N (1r,3as,5ar,5br,7ar,11ar,11br,13ar,13br)-5a,5b,8,8,11a-pentamethyl-9-oxo-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1h-cyclopenta[a]chrysene-3a-carbaldehyde Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MHAVMNJPXLZEIG-CNRMHUMKSA-N 0.000 description 1
- VLFUANNVMXKBPF-ZAPOICBTSA-N (1s,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carbaldehyde Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C VLFUANNVMXKBPF-ZAPOICBTSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IXELFRRANAOWSF-FNORWQNLSA-N (E)-Ajoene Chemical compound C=CCSS\C=C\CS(=O)CC=C IXELFRRANAOWSF-FNORWQNLSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- VMSGKWPBDUHCHC-UHFFFAOYSA-N 1,2,2-trihydroxycyclohexane-1-carboxylic acid Chemical compound OC(=O)C1(O)CCCCC1(O)O VMSGKWPBDUHCHC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- WXUAQHNMJWJLTG-UHFFFAOYSA-N 2-methylbutanedioic acid Chemical compound OC(=O)C(C)CC(O)=O WXUAQHNMJWJLTG-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RVDLHGSZWAELAU-UHFFFAOYSA-N 5-tert-butylthiophene-2-carbonyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)S1 RVDLHGSZWAELAU-UHFFFAOYSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- BZNIIOGSANMIET-JEKRXEKZSA-N Allobetulin Natural products O[C@@H]1C(C)(C)[C@H]2[C@](C)([C@@H]3[C@](C)([C@@]4(C)[C@@H]([C@H]5[C@H]6C(C)(C)CC[C@]5(CO6)CC4)CC3)CC2)CC1 BZNIIOGSANMIET-JEKRXEKZSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000125205 Anethum Species 0.000 description 1
- 235000007227 Anethum graveolens Nutrition 0.000 description 1
- 235000017311 Anethum sowa Nutrition 0.000 description 1
- 241000254175 Anthonomus grandis Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001532036 Aspidistra Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- XNZIMRUZBOZIBC-JVRMVBBZSA-N Betulinic acid methyl ester Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@H]3[C@H](C(C)=C)CC[C@]3(C(=O)OC)CC[C@]21C XNZIMRUZBOZIBC-JVRMVBBZSA-N 0.000 description 1
- SLJTWDNVZKIDAU-SVAFSPIFSA-N Betulonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C SLJTWDNVZKIDAU-SVAFSPIFSA-N 0.000 description 1
- SLJTWDNVZKIDAU-CKURCAGRSA-N Betulonic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O SLJTWDNVZKIDAU-CKURCAGRSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241001333452 Bridelia insulana Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000220451 Canavalia Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000182633 Cinchona succirubra Species 0.000 description 1
- 235000006768 Cinchona succirubra Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- VLFUANNVMXKBPF-UHFFFAOYSA-N Coniferin 2'-O-beta-D-apiofuranoside Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C=O)CCC(C)C(C)C5C4=CCC3C21C VLFUANNVMXKBPF-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000218916 Cycas Species 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 229920002707 Digallic acid Polymers 0.000 description 1
- 240000004530 Echinacea purpurea Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 235000007810 Eryngium campestre Nutrition 0.000 description 1
- 101100129915 Escherichia coli (strain K12) melB gene Proteins 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- KDKROYXEHCYLJQ-DYXVGVPESA-N Ginkgolide M Chemical compound C[C@H]1[C@H]2[C@H]([C@@H](C34[C@]25C(=O)O[C@@H]3[C@@H]([C@H](C46[C@H](C(=O)O[C@H]6O5)O)C(C)(C)C)O)O)OC1=O KDKROYXEHCYLJQ-DYXVGVPESA-N 0.000 description 1
- CBAUUWCEZZNYTD-OOWJTCQTSA-N Ginkgolide M Natural products O=C1[C@@H](C)[C@@H]2[C@@H]([C@@H](O)[C@@]34[C@H]5[C@@H](O)[C@@H](CC(C)C)[C@@]63[C@@H](O)C(=O)O[C@@H]6O[C@@]24C(=O)O5)O1 CBAUUWCEZZNYTD-OOWJTCQTSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001504070 Huperzia Species 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- FELCJAPFJOPHSD-ROUWMTJPSA-N Lup-20(29)-en-28-al, 3beta-hydroxy- Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FELCJAPFJOPHSD-ROUWMTJPSA-N 0.000 description 1
- RCQBVCISWCRYBO-SOYDKUNTSA-N Lupenone Natural products CC(=C)[C@@H]1CC[C@]2(C)CC[C@@H]3[C@H](CC[C@H]4[C@@]3(C)CC[C@H]5C(C)(C)C(=O)CC[C@]45C)[C@@H]12 RCQBVCISWCRYBO-SOYDKUNTSA-N 0.000 description 1
- GRBHNQFQFHLCHO-UHFFFAOYSA-N Lupenonq Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C GRBHNQFQFHLCHO-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 235000010735 Noci del Sudan Nutrition 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 229920000473 Phlobaphene Polymers 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 240000005166 Polygonatum biflorum Species 0.000 description 1
- 235000004506 Polygonatum multiflorum Nutrition 0.000 description 1
- 244000233952 Polygonum bistorta Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 244000057899 Rudbeckia hirta var. pulcherrima Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- NPJICTMALKLTFW-NEOYQNEMSA-N Sitosteryl glucoside Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1OC(CO)[C@@H](O)C(O)C1O NPJICTMALKLTFW-NEOYQNEMSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241001116495 Taxaceae Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000592342 Tracheophyta Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- ZRJLCVQCZVXUFB-MRVPVSSYSA-N Valerianine Natural products O(Cc1c2c([C@H](C)CC2)cnc1)C ZRJLCVQCZVXUFB-MRVPVSSYSA-N 0.000 description 1
- ZRJLCVQCZVXUFB-QMMMGPOBSA-N Valerianine Chemical compound COCC1=CN=CC2=C1CC[C@@H]2C ZRJLCVQCZVXUFB-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000567256 Zannichellia obtusifolia Species 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- IXELFRRANAOWSF-CYBMUJFWSA-N ajoene Natural products C=CCSSC=CC[S@](=O)CC=C IXELFRRANAOWSF-CYBMUJFWSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- BZNIIOGSANMIET-UHFFFAOYSA-N allobetuline Natural products CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3)(C)C2CCC1C1C2OCC13CCC2(C)C BZNIIOGSANMIET-UHFFFAOYSA-N 0.000 description 1
- BZNIIOGSANMIET-HWNNWUPFSA-N allobetulinol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]([C@]1(C)CC3)(C)[C@@H]2CC[C@@H]1[C@H]1[C@H]2OC[C@]13CCC2(C)C BZNIIOGSANMIET-HWNNWUPFSA-N 0.000 description 1
- 150000008126 allyl sulfides Chemical class 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- HITDPRAEYNISJU-UHFFFAOYSA-N amenthoflavone Natural products Oc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HITDPRAEYNISJU-UHFFFAOYSA-N 0.000 description 1
- YUSWMAULDXZHPY-UHFFFAOYSA-N amentoflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 YUSWMAULDXZHPY-UHFFFAOYSA-N 0.000 description 1
- HVSKSWBOHPRSBD-UHFFFAOYSA-N amentoflavone Natural products Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HVSKSWBOHPRSBD-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000012863 analytical testing Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000001528 anethum graveolens l. herb oil Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- GYIWFHXWLCXGQO-UHFFFAOYSA-N barium(2+);ethanolate Chemical compound [Ba+2].CC[O-].CC[O-] GYIWFHXWLCXGQO-UHFFFAOYSA-N 0.000 description 1
- BQDSDRAVKYTTTH-UHFFFAOYSA-N barium(2+);methanolate Chemical compound [Ba+2].[O-]C.[O-]C BQDSDRAVKYTTTH-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- XNZIMRUZBOZIBC-UHFFFAOYSA-N betulinic acid methyl esther Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C(C)=C)CCC3(C(=O)OC)CCC21C XNZIMRUZBOZIBC-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- JHLCADGWXYCDQA-UHFFFAOYSA-N calcium;ethanolate Chemical compound [Ca+2].CC[O-].CC[O-] JHLCADGWXYCDQA-UHFFFAOYSA-N 0.000 description 1
- AMJQWGIYCROUQF-UHFFFAOYSA-N calcium;methanolate Chemical compound [Ca+2].[O-]C.[O-]C AMJQWGIYCROUQF-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- IXELFRRANAOWSF-UHFFFAOYSA-N cis-ajoene Natural products C=CCSSC=CCS(=O)CC=C IXELFRRANAOWSF-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000021310 complex sugar Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 229940119228 dill seed oil Drugs 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 description 1
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 208000028327 extreme fatigue Diseases 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- LMEHVEUFNRJAAV-UKWFQYJJSA-N ginkgolide-j Chemical compound O([C@H]1O2)C(=O)[C@H](O)[C@@]31[C@]14C[C@@H]5OC(=O)[C@@H](C)[C@]5(O)[C@@]12C(=O)O[C@@H]4[C@H](O)[C@H]3C(C)(C)C LMEHVEUFNRJAAV-UKWFQYJJSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003722 gum benzoin Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 1
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
- AZVCGYPLLBEUNV-UHFFFAOYSA-N lithium;ethanolate Chemical compound [Li+].CC[O-] AZVCGYPLLBEUNV-UHFFFAOYSA-N 0.000 description 1
- HAUKUGBTJXWQMF-UHFFFAOYSA-N lithium;propan-2-olate Chemical compound [Li+].CC(C)[O-] HAUKUGBTJXWQMF-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- GRBHNQFQFHLCHO-BHMAJAPKSA-N lupenone Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C GRBHNQFQFHLCHO-BHMAJAPKSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- CRGZYKWWYNQGEC-UHFFFAOYSA-N magnesium;methanolate Chemical compound [Mg+2].[O-]C.[O-]C CRGZYKWWYNQGEC-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- QGPIUZIWMRUUCS-UHFFFAOYSA-N oleanolic aldehyde Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(C=O)CCC(C)(C)CC5C4=CCC3C21C QGPIUZIWMRUUCS-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002966 pentacyclic triterpenoids Chemical class 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- NQJGJBLOXXIGHL-UHFFFAOYSA-N podocarpusflavone A Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O NQJGJBLOXXIGHL-UHFFFAOYSA-N 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- WQKGAJDYBZOFSR-UHFFFAOYSA-N potassium;propan-2-olate Chemical compound [K+].CC(C)[O-] WQKGAJDYBZOFSR-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 150000003364 shikimic acids Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 235000018984 snakeroot Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- WBQTXTBONIWRGK-UHFFFAOYSA-N sodium;propan-2-olate Chemical compound [Na+].CC(C)[O-] WBQTXTBONIWRGK-UHFFFAOYSA-N 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000007892 solid unit dosage form Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019630 tart taste sensations Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- ARSRJFRKVXALTF-UHFFFAOYSA-N tricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 ARSRJFRKVXALTF-UHFFFAOYSA-N 0.000 description 1
- CMPNIWQMRYYTMK-UHFFFAOYSA-O tricetinidin Natural products [O+]=1C2=CC(O)=CC(O)=C2C=CC=1C1=CC(O)=C(O)C(O)=C1 CMPNIWQMRYYTMK-UHFFFAOYSA-O 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000017468 valeriana Nutrition 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 150000008122 vinyldithiins Chemical class 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
Definitions
- Birch bark is a low-value waste product in the forest industry today. Ekman, R., Holzaba, (1983) 37, 205. Approximately 230,000 tons of birch bark are generated per year. For example, a single paper mill can generate 70 tons of birch bark per day. Thus, vast quantities of birch bark and its chemical components are available. Birch bark is a potential source of a variety of organic chemicals. Several triterpenoids have been identified in birch bark extracts.
- lupeol, betulin, betulinic aldehyde, betulinic acid, methyl betulinate, lupenone, betulonic aldehyde, betulonic acid, /3-amyrin, erythiOdiol, oleanolic aldehyde, oleanolic acid, methyl leanolate and acetyl oleanolic acid are all present in the outer bark o ⁇ Betula verrucosa. Eckerman, C, (1985) Paperi ja Puu, No. 3, 100.
- Betulin is also a useful starting material for preparing alobetulin and derivatives thereof, which posses useful pharmacological properties. Betulin can be converted to betulinic acid, which is useful as a therapeutic agent.
- Pisha E. et al., (1995) J. M. Nature Medicine, 1,
- betulinic acid has anti-tumor activity against human melanoma, e.g., MEL-1, MEL-2 and MEL-4.
- Fujioka, T. et al, J. Nat. Prod.. (1994) 57, 243-247 discloses that betulinic acid has anti-HIV activity in H9 lymphocytic cells.
- Current methods for isolating the chemical constituents of birch bark are deficient in several ways. For example, betulin has been extracted from the bark of white-barked birches in amounts up to 20%, based on the dry weight of the bark.
- Russian Patent Nos. RU2175326 discloses methods of preparing betulin, and derivatives thereof.
- the methods disclosed in Russian Patent No. RU2192879 include birch bark milling, separation of birch bark fibers, extraction of birch bark, separation of solution from extracted birch bark, and solvent removal from solution.
- the birch bark extraction is carried out with toluene at temperature of 90°C-110°C for 1.5-3.0 h, and the solution is filtered at a temperature of 40°C-50°C.
- the toluene betulin solution is cooled for 6-10 h to a temperature of 15°C - 5°C.
- the methods described in the '776 patent application are not able to effectively remove triterpenoids such as betulin-3-caffeate, betulinic acid, lupeol, esters of fatty acids, fatty acids, polyphenols and tannins, from the birch bark or birch bark extract.
- the process described in the '776 patent application is unsuitable for the industrial scale recovery of betulin, as well as lupeol and betulinic acid.
- the yields and purities of betulin disclosed in the '776 patent application are believed to be erroneous, utilizing the processes described therein. Even if accurate, the yields and purities of betulin disclosed in the '776 patent application can be improved.
- the processes described therein cannot be practiced on larger, industrial scales (e.g., kilograms or tons). A need therefore exists for safer, more cost-efficient and/or more efficient methods to obtain commercial quantities (e.g., tons) of betulin; as well as commercial quantities (e.g., kg) of lupeol and betulinic acid from birch bark.
- Summary of the Invention The process of the present invention is suitable for obtaining betulin, lupeol and betulinic acid from birch bark, in a yield of about 10 wt.% to about 12 wt.%, about 2.5 wt.% and about 2 wt.%, respectively.
- the betulin, lupeol and betulinic acid obtained using the methods of the present invention are relatively pure.
- the betulin will typically include less than about 0.02 wt.% of betulinic acid.
- commercial quantities (e.g., tons) of betulin; as well as commercial quantities (e.g., kg) of lupeol and betulinic acid can be obtained from birch bark.
- the methods of the present invention can also be employed to effectively remove betulin-3-caffeate, betulinic acid, esters of fatty acids, fatty acids, polyphenols and tannins from the birch bark or birch bark extract.
- betulin-3-caffeate and esters of fatty acids are effectively hydro lyzed upon contact and heating with the base.
- the betulin-3-caffeate is converted to betulin, which increases the overall yield of betulin; and the esters of fatty acids provide methanol and a salt of betulinic acid, which precipitates and can be removed from the reaction mixture.
- the betulinic acid precipitates as a basic salt, and can be removed from the reaction mixture.
- the polyphenols also precipitate as polyphenolates, which can be removed from the reaction mixture.
- the present invention provides a method for obtaining a natural product from plant material.
- the method includes: (a) contacting plant material with a solvent to provide a first mixture; (b) separating the plant material from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; and (f) concentrating the fourth mixture, or precipitating solids from the fourth mixture, to provide a natural product.
- an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (i
- the present invention also provides a method for selectively obtaining one or more non-acidic compounds from plant tissue in the presence of one or more acidic compounds.
- the method includes: (a) contacting plant material with a solvent to provide a first mixture; (b) separating the plant material from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; and (f) concentrating the fourth mixture, or precipitating solids from the fourth mixture, to provide a natural product.
- the present invention also provides a method for obtaining betulin from birch bark.
- the method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or
- (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about
- the present invention also provides a method for obtaining lupeol from birch bark.
- the method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; (f) precipitating solids from the fourth mixture; (g) separating the solids from the fourth mixture to provide a mother liquor; (h) concentrating the mother liquor to provide a fifth mixture; (i) washing the fifth mixture with a polar organic solvent to provide
- the process can optionally further include (1) recrystallizing the lupeol from a polar organic solvent to provide pure lupeol and (m) drying the pure lupeol.
- the present invention also provides a method for obtaining betulinic acid from birch bark.
- the method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture; (f) washing the solid with water to provide a second solids; (g) neutralizing or acidifying the second solids with an aqueous acid, thereby providing a fourth mixture; (h) separating crude betulinic acid from the fourth mixture.
- an organic solvent that (i)
- the process can optionally further include (i) crystallizing the crude betulinic acid from polar organic solvent to provide pure betulinic acid and (j) drying the pure betulinic acid.
- the present invention also provides a method for purifying an extract of a natural product.
- the method includes: (i) contacting an extract of a natural product with an aqueous base, to provide a first mixture; (ii) heating the first mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the first mixture, thereby providing a second mixture; (iii) separating solids from the second mixture, to provide a third mixture; and (iv) concentrating the third mixture or precipitating solids from the third mixture, to provide a p ⁇ rified natural product.
- an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least
- the present invention also provides a compound obtained from the method of the present invention.
- the present invention also provides a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a compound obtained from the method of the present invention.
- the present invention also provides a cosmetic composition that includes a cosmetically acceptable carrier and a compound obtained from the method of the present invention.
- a cosmetic composition that includes a cosmetically acceptable carrier and a compound obtained from the method of the present invention.
- Figure 1 illustrates a block flow diagram depicting the isolation of betulin, lupeopl, and/or betulinic acid from birch bark, employing distillation.
- Figure 2 illustrates a block flow diagram depicting the isolation of acidic components (natural products) and non-acidic components (natural products) from plant material, employing distillation.
- Specific values listed below for ranges are for illustration only; they do not exclude other defined values or other values within defined ranges.
- triterpene or “triterpenoid” refers to a plant secondary metabolite that includes a hydrocarbon, or its oxygenated analog, that is derived from squalene by a sequence of straightforward cyclizations, functionalizations, and sometimes rean-angement. Triterpenes or analogues thereof can be prepared by methods known in the art, i.e., using conventional synthetic techniques or by isolation from plants. Suitable exemplary triterpenes and the biological
- triterpene refers to one of a class of compounds having approximately 30 carbon atoms and synthesized from six isoprene units in plants and other organisms. Triterpenes consist of carbon, hydrogen, and optionally oxygen. Most triterpenes are secondary metabolites in plants. Most, but not all, triterpenes are pentacyclic.
- triterpenes examples include betulin, allobetulin, lupeol, friedelin, and all sterols, including lanosterol, stigmasterol, cholesterol, jS-sitosterol, and ergosterol.
- betulin refers to 3/3,28-dihydroxy-lup-20(29)-ene.
- Betulin is a pentacyclic triterpenoid derived from the outer bark of paper birch trees (Betula papyrifera, B. pendula, B. verucosa, etc.). It can be present at concentrations of up to about 24% of the bark of white birch. Merck Index, twelfth edition, page 1236 (1996). Stmcturally, betulin is shown below:
- betulinic acid refers to 9-hydroxy-l-isopropenyl- 5a,5b,8,8,l la-pentamethyl-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid. Structurally, betulinic acid is shown below:
- lupeol refers to lup-20 (29)-en-3 /3-ol. Lupeol is also found in birch bark and in other plant sources. Lupeol is present at concentrations of about 1.5-3% of the birch bark and at up to about 8.2% in Canavalia ensifomiis, a plant widespread in the humid tropics of Asia and Africa. Structurally, lupeol is shown below:
- natural product refers to naturally occurring compounds that are end products of secondary metabolism; often, they are unique compounds for particular plants or species of plants.
- the compounds can be derived from plant material, e.g., birch bark. Such compounds can include, e.g., triterpenes or triterpenoids.
- the natural product can include a single compound, or can include one or more different compounds. Additionally, these one or more different compounds can be structurally related or stmcturally unrelated.
- a “non-acidic compound” refers to a natural product that comprises lupeol, betulin, taxol, paclitaxel, echinacea extract, valerian root extract, ginkgolide A, ginkgolide B, ginlcgolide C, bilobalide, garlic extract, ginseng extract, aloe gel, barbaloin, cranbeny extract, eleutheroside A, eleutheroside B, eleutheroside C, eleutheroside D, eleutheroside E, eleutheroside
- an "acidic compound” refers to a natural product that acidic compounds comprises betulin acid, betulin-3-caffeate, tannin, lipid, phenol, caffeic acid, cichoric acid, valerenic acid, isovaleric acid, flavonoid, quercetin, kaempferol, catechin, lignin, shikimic acid, succinic acid, amino acid, nicotinic acid, pantothenic acid, anthraquinone, acidic galactan, benzoic acid, quinic acid, malic acid, citric acid, hippuric acid, phenolic acid, feralic acid, .
- plant material or “plant tissue” refers to a collection of similar cells of a plant, that typically act together to perform a particular function.
- the term refers to the tissue of any organism of the plant kingdom, as opposed to one of the animal kingdom or of the kingdoms of Fungi, Protista, or Monera.
- the plant tissue can be any portion or portions of the plant (e.g., bark, roots, leaves, flowers, needles, bulbs, benies, rhizomes, rootstocks, stems, and seeds), as well as the entire plant.
- the tissues of a plant (“plant tissue”) generally fall into three main categories: dermal tissue, ground tissue, and vascular tissue.
- Dermal tissue refers to the "skin" layer of all plant organs and is responsible for environmental interaction (light passage, gas exchange, pathogen recognition and protection, color display, etc.).
- Demial tissue is composed of epidermal cells, closely packed cells that secrete a waxy cuticle that aids in the prevention of water loss.
- Ground tissue lies between dermal tissue and vascular tissue.
- the ground tissue comprises the bulk of the primary plant body. Parenchyma, collenchyma, and sclerenchyma cells are common in the ground tissue, h roots, the ground tissue may store sugars or starches to fuel the spring sap flow; in leaves, the ground tissue is the layer responsible for photosynthesis (the mesophyll).
- Vascular tissue transports food, water, hormones and minerals within the plant.
- Vascular tissue includes xylem, phloem, parenchyma, and cambium cells.
- bark refers to the dry, dead outer covering of woody branches, stems and roots of plants that is very distinct and separable from the wood itself. It includes all tissue outside the cambium (growth layer between bark and wood).
- leaf or leafaves refer to those parts of a plant which grow along the sides of branches or stems or at the bases of plants. Most are green and contain chlorophyll, though they vary in their shapes and sizes. Leaves are the part of the plant that ordinarily performs photosynthesis (the process that converts sunlight and carbon dioxide into energy).
- needle generally refers to a narrow stiff leaf, such as those of conifers (e.g., pine trees).
- root refers to the part of a plant, normally underground, that absorbs nutrients and anchors the plant into the ground.
- bulb refers to a spheroidal body growing from a plant either above or below the ground (usually below), which is usually a bud, consisting of a cluster of partially developed leaves, and producing, as it grows, a stem above, and roots below, (e.g., the onion or tulip bulb).
- a true bulb is a complete package containing next year's plant (flower) already forming inside.
- the contents of the bulb are often enclosed in protective, fleshy scales, which are held together by a small basal plate.
- the scales are modified leaves that contain enough nutrients to sustain the plant through dormancy and early growth. They may be loose and open like those of a lily, or tightly closed like those of a hyacinth.
- a paper-thin tunic protects the scales (lilies don't have a tunic). Roots will grow from the bulb's basal plate.
- "beny” refers to any small fruit that is pulpy or succulent throughout, having seeds loosely imbedded in the pulp, such as the cunant, grape, or bluebeny.
- Beny can be further defined as an indehiscent fruit derived from a single ovary and having the whole wall fleshy, such as the grape or tomato. Furthermore, benies come in various stmctures including simple, such grape; bluebeny, cranberry, or aggregate, such as blackbeny; raspbeny, strawbeny mulbeny.
- rhizome refers to a horizontal, usually underground stem that often sends out roots and shoots from its nodes (also called rootstalk or rootstock).
- rootstock refers to a robust plant that provides the root system in grafting, also known as a stock. Scions and buds are grafted and budded to a rootstock or stock.
- Rootstock also refers to the elongated and often thick rhizomes of certain perennial herbaceous plants such as the Iris, Aspidistra and Solomon's Seal. .
- stem refers to the main (usually aerial) axis (sometimes refened to as the trunk or stalk) of a tree, shrub, or plant.
- stem also refers to the part of the plant that supports the leaves, flowers or fruits of a plant, such as the peduncle of a fruit or the pedicel of a flower.
- seed refers to a ripened ovule, consisting of an embryo with one or more integuments, or coverings, such as an apple seed, a cunant seed, dill seed, or kola nut seed. By germination, most seeds produces a new plant. "Seed” also refers to any small seedlike fruit, though it may consist of a pericarp, or even a calyx, as well as the seed proper, such as a parsnip seed or thistle seed. The seed proper has an outer and an inner coat, and within these the kernel or nucleus. The kernel is either the embryo alone, or the embryo enclosed in the albumen, which is the material for the nourishment of the developing embryo. The scar on a seed, left where the stem parted from it, is called the hilum, and the closed orifice of the ovule, the micropyle.
- the plant can be a bryophyte or vascular plant. More specifically, the plant can be grass, flower or a tree and the plant tissue can be any part of the grass, flower or tree.
- Specific plants, flowers, and trees include, e.g., Moss (e.g., Club Moss), Horsetail, Fern, Conifer, Cycad, Ginkgo biloba (Ginkgo), Taxus yunnanesis (yew tree), Echinacea spp., Valeriana officinalis, Allhmi sativum (garlic), Panax ginseng, aloe vera, Vaccinium macrocarpon, Eleutherococcus senticosus, Piper methysticum, dill, kola nut, and cinchona.
- Moss e.g., Club Moss
- Horsetail Fern, Conifer, Cycad
- Ginkgo biloba Ginkgo
- Taxus yunnanesis yew tree
- birch refers to any of the several deciduous tress of the genus Betula.
- the birches comprise the family Betulaceae in the order Fagales.
- Birch trees include, for example, white birch, B. alba; sweet, black or cheny birch, B. lenta; monarch birch, B. maximowicziana; dwarf or arctic birch; B. nana; Japanese white birch, B. platphyla japonica; smooth-bark birch, B. pubescens; yellow birch, B.
- alleghaniensis paper, white or canoe birch, B. papyrifera; gray birch, B. populifolia; river birch, B. nigra; and the European birches, B. pubescens; B. alba and B. pendula.
- birch can be B. alba, B. lenta, B. maximowicziana, B. nana, B. platyphylajaponica, B. pubescens, B. alleghaniensis, B. papyrifera, B. populifolia, B. nigra or B. pendula.
- a specific birch for use in the processes of the present invention is B. papyrifera.
- Taxus or “yew” refers to plants belonging to Taxaceae Gymnopenmae. There are 11 species and five sub-species of Taxus in the world, mainly found in East Asia, North America, and Europe; , "Echinacea spp.” Refers to a perennial native to North American which resembles a black-eyed Susan and is called Dchinacea, purple coneflower or snake root; "Valeriana offlcinalis” or “valerian” refers to the plant Valeriana of ⁇ cinalis of the valerianaceae family, which is also known as valerian, phu, allheal, great wild valerian, amantilla, setwall, setewale, capon's tail; "Allium sativum” refers to garlic; “Panax ginseng” refers to ginseng, commonly called Korean ginseng, Chinese ginseng or American ginseng. Asian ginseng is a member of the
- Araliaceae family which also includes the closely related American ginseng, Panax quinquefolius, and less similar Siberian ginseng; "Eleutherococcus senticosus,” refers to “eleuthero” (which contains eleutheroside A, eleutheroside B (syringin), eleutheroside C, eleutheroside D, eleutheroside E (syringaresinol di-O- ⁇ -D-glucoside, liriodendrin), and eleutheroside G, among other constituents); "Aloe” refers to any of the over 500 different species of Aloe.
- Aloe Vera is a member of the Lily family and is very-cactus like in its characteristics. This unique plant also belongs to a larger plant family called "Xeroids". Of the 500+ species of Aloe, Aloe barbaclensis miller (Aloe Vera species) is prefened; "Vaccinium macrocarpon” refers to cranbeny; “Piper methysticum,” a member of the pepper family, refers to a plant native to the South Sea Islands of Micronesia, Melanesia and Polynesia; "Kola vera,” of the family N.O.
- Sterculiaceae also known as "Kola nut” refers to the tree that grows about 40 feet high and has yellow flowers spotted with purple; and "Cinchona,” belongs to the family N.O. Rubiaceae and refers to Peruvian bark (Cinchona succimbra) which is an evergreen tree that grows 15 to 45 feet in height.
- Non-acidic compounds and acidic compounds The specific non-acidic compounds and acidic compounds that can be isolated from the plant tissue will depend, in part, upon the specific plant tissue that is being extracted.
- the bark of Taxus yunnanesis can be extracted employing the methods described herein to provide taxol (paclitaxel) as the non-acidic compound and tannin, fatty acids, and phenols as the acidic compounds
- the needles of the Yew tree can be extracted employing the methods described herein to provide taxol (paclitaxel) as the non-acidic compound, and tannin, fatty acids, and phenols as the acidic compounds
- the root of the Echinacea spp the bark of Taxus yunnanesis can be extracted employing the methods described herein to provide taxol (paclitaxel) as the non-acidic compound and tannin, fatty acids, and phenols as the acidic compounds
- the root of the Echinacea spp the bark of Taxus yunnanesis
- Echinacea extract as the non-acidic compound and tannin, caffeic acid, and cichoric acid as the acidic compounds
- the root of the Valeriana officinalis can be extracted employing the methods described herein to provide Valerian root extract as the non-acidic compound and valerenic acid, isovaleric acid, and tannins as the acidic compounds
- the roots, bark, leaves, or any combination thereof of the Ginkgo biloba can be extracted employing the methods described herein to provide Ginkgolide A, Ginkgolide B, Ginkgolide C, and bilobalide as the non-acidic compounds and tannins, flavonoids (e.g., quercetin, kaempferol, catechin), lignins, shikimic, and succinic acids as the acidic compounds
- the bulb of the Allium sativum can be extracted employing the methods described herein to provide garlic extract as the non-acidic compound and fatty acids and amino acids as the acidic compounds
- Table 1 Non-acidic compounds and acidic compounds that can be isolated from specific plant tissue.
- “Paclitaxel” refers to [2aR-[2a ⁇ ,4 ⁇ ,4a ⁇ ,6 ⁇ ,9 ⁇ ( ⁇ R*, ⁇ S*),- l l, ⁇ l2 ⁇ ,12a ⁇ ,12b ⁇ ]]- ⁇ -(Benzoylamino)- ⁇ -hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,l l,12,12a,12b- dodecahydro-4,1 l,-dihydroxy-4a,8, 13, 13-tetramethyl-5-oxo-7,l 1-methano-lH- cyclodeca[3,4]benz[l,2-b]oxet-9-yl ester.
- Echinacea extract is believed to include essential oil, polysaccharides, such as inulin, polyacetylenes, betain, glycoside, sesquiterpenes and caryophylene. Echinacea extract is also believed to contain copper, iron, tannins, protein, fatty acids, fat-soluble alkylamides, caffeic acid glycoside (echinacoside), and vitamins A, C, and E.
- valeriana officinalis extract is a very effective sedative and is used most often to help insomnia, especially due to stress. It has an advantage over prescription sedatives in that it is not habit forming. Valerian has many actions besides its well-known sedative effects. It strengthens the heart and in some cases lower blood pressure.
- valerian which vary in potency and can be used similarly, although V. officinalis is the prefened plant.
- Other constituents are a volatile oil, which includes isovalerianic acid and bomeol; choline; flavonoids; sterols and several alkaloids, including actinidine, valerianine, valerine, and chatinine.
- Valepotriates are not water-soluble, but valeric acid is and may be the constituent most likely to produce valerian's sedative effect, especially when used as it was traditionally in water extracts (teas) or water/alcohol extracts (tinctures).
- the genus Ziziphus (ber, jujube) belongs to the buckthorn familiy (Rhamnaceae). It is a genus of about 100 species of deciduous or evergreen trees and shrubs distributed in the tropical and subtropical regions of the world. Some species, like Z. mauritiana and Z. jujuba, occur on nearly every continent, whereas other species, like Z. nummularia, Z. spina-christi and Z.
- Ziziphus species can grow either as trees and shrubs (Z. mauritiana, Z. rotundifolia, Z. jujuba, Z. mucronata) or exclusively as small shrubs or bushes (Z. nummularia, Z. lotus, Z. spina-christi, Z. obtusifolia). This is a tree that may be used for manufacturing betulinic acid.
- Many studies have provided clinical evidence that ginkgo prevents many problems throughout the entire body. Ginkgo is gaining recognition as a brain tonic that enhances memory because of its positive effects on the vascular system, especially in the cerebellum.
- Ginkgo may help to counteract the effects of aging, including mental fatigue and lack of energy.
- Ginkgo has two groups of active substances, flavonoids (a three-ringed molecule with hydroxyl (OH) groups attached) and terpene lactones, including ginkgolides A, B, and C, bilobalide (a sesquiterpene), quercetin (a flavonoid), and kaempferol (a flavonoid).
- the constituents of gingko include terpenoids (bilobalide), diterpenoids (ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J, ginkgolide M), flavonoids: flavones (luteolin, tricetin, 2-hydroxyluteolin), biflavones (amentoflavone, ginkgetin, isoginkgetin, sciadoptysin, 5-methoxybilobetin, bilobetin), flavonols
- Ginkgolides have been shown to control allergic inflammation, anaphylactic shock and asthma.
- Ginkgo extract is generally derived from dried ginkgo leaves, but also may be derived from gingko root or bark.
- Garlic contains compounds that are antibacterial, antifungal and reduce blood clotting. In order for the active ingredient that gives garlic its characteristic odor and its therapeutic effects to be released, the garlic clove (or bulb) must be cut or crashed. This releases an enzyme that causes the formation of allicin, the component responsible for garlic's odor and medicinal activity.
- Active constituents present in garlic include the sulphur compound allicin, produced by crashing or chewing fresh garlic, which in turn produces other sulphur compounds: ajoene, allyl sulfides, and vinyldithiins.
- “Ginseng” is believed to increase energy, counter the effects of stress, and enhance intellectual and physical perfomiance. Thirteen ginsenosides have been identified in ginseng, including ginsenosides Rgl and Rbl.
- Other constituents include the panaxans, which are believed to help lower blood sugar, and the polysaccharides (complex sugar molecules), which are believed to support immune function. Also, long-term intake may be linked to a reduced risk of cancer.
- aloe is a mild anesthetic, relieving itching, swelling, and pain: it also is antibacterial and antifungal, increases blood flow to wounded areas, and stimulates fibroblasts, the skin cells responsible for wound healing.
- "Cranbeny” has astringent applications for the urinary tract and is a traditional remedy for bladder infections and kidney-related disorders. Two components of cranbeny juice have been shown to inhibit the adherence of E. coli to uroepithelial cells. The first is fructose. The second is proanthocyanidin, the chemical structure of which has been elucidated. Fructose inhibits the adherence of type-1 fimbriated E.
- Kavalactones consists of an oleoresin from which kavalactones originate, starch, sugars, proteins, vitamins Bl, B2, B3, B6, folic acid and E, potassium, manganese, biotin, choline, inositol, fat, glycynhizin, lecithin, pantothenic acid, para-aminobenzoic acid, pentacyclic terpenes, phosphorous, and a yellow dye.
- Kavalactones are considered the most active constituents in the plant. The main use for kava today is in the treatment of anxiety. It is also an excellent muscle relaxant and has diuretic and urinary antiseptic properties, so it may be useful in urinary cystitis and prostatitis.
- Kava also shows pain-relieving properties.
- "Kola vera” or “Cola vera” seeds are said to contain a glucoside, Kolanin (this substance may be a mixture of Kola red and caffeine). The seeds also contain starch, fatty matter, sugar, and a fat decomposing enzyme acting on various oils.
- "Dill seed” is an herbal medicine that is used to reduce gas, upset stomach, and colic pains. It is also used to promote the flow of milk in breastfeeding mothers, and to help control bad breath and hiccups. Other names for Dill Seed include: Anethum Graveolens, Dill, and Dillweed.
- tannin refers to tannic acid or gallotannic acid.
- Tannin varies somewhat in composition, depending on the source, having the approximate empirical formula C 76 H 52 0 6 . Tannic acid is a colorless to pale yellow solid; it is believed to be a glucoside in which each of the five hydroxyl groups of the glucose molecule is esterified with a molecule of digallic acid. Tannin is used in tanning animal skins to make leather; it transforms certain proteins of animal tissue into compounds that resist decomposition. It is also used in manufacturing inks, as a mordant in dyeing, and in medicine as an astringent and for treatment of burns.
- fatty acids refers to a long-chain of carboxylic acids that may either be saturated (without double bond) or non-saturated (with double bond). It refers to any acid derived from fats by hydrolysis (e.g., oleic acid, palmitic acid, or stearic acid); any long-chain monobasic organic acid.
- phenols refers to compounds that include a C 6 H 5 OH backbone. They are aromatic alcohols that are optionally substituted by one or more substituents. Phenols exhibits weak acidic properties and are sometimes called carbolic acids, especially when in water solution.
- caffeic acid refers to 3-(3,4-Dihydroxyphenyl)-2- propenoic acid.
- valeric acid refers to pentanoic acid; valerianic acid; and propylacetic acid.
- isovaleric acid refers to 3-Methylbutanedioic acid and isovalerianic.
- flavonoid refers to polyphenols that have a carbon skeleton. They have an acidic nature due to the phenol groups.
- quercetin refers to 2-(3,4-Dihydroxyphenol)-3,5,7- trihydroxy-4H-l -benzopyran-4-one.
- kaempferol refers to 3,5,7-Trihydroxy-2-(4- hydroxyphenyl)-4H- 1 -benzopyran-4-one.
- catechin refers to (2R-trans)-2-(3,4-dihydroxyphenyl)- 3,-4-dihydro-2H-l-benzopyran-3,5,7-triol.
- lignin refers to a highly polymerized and complex chemical compound especially common in woody plants. The cellulose walls of the wood become impregnated with lignin, a process called lignification, which i greatly increases the strength and hardness of the cell and gives the necessary rigidity to the tree.
- amino acids refers to any one of a class of simple organic compounds containing carbon, hydrogen, oxygen, nitrogen, and in certain cases sulfur. These compounds are the building blocks of proteins. They are characterized by the presence of a carboxyl group (COOH) and an amino group (NH 2 ).
- the 20 amino acids commonly found in animals are alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. More than 100 less common amino acids also occur in biological systems, particularly in plants. Every amino acid except glycine can occur as either of two optically active stereoisomers, D or L; the more common isomer in nature is the L-fonn.
- shikimic acid refers to [3R-(3 ⁇ ,4 ⁇ ,5 ⁇ ]-3,4,5- Trihydrooxy- 1 -cyclohexene- 1 -carboxylic acid.
- succinic acid refers to butanedioic acid (HOOCCH 2 CH 2 COOH).
- nicotinic acid refers to 3-Pyridinecarboxylic acid.
- pantothenic acid refers to "(R)-N-(2,4-Dihydroxy-3,3- dimethyl- 1 -oxobutyl)- ⁇ -alanine.
- anthraquinone refers to 9,10-anthracenedione.
- acidic galactan refers to a poly sugar with attached carboxylic groups.
- benzoic acid refers to benzoic acid, C 6 H 5 CO 2 H. It is the simplest aromatic carboxylic acid.
- benzyl alcohol e.g., benzyl alcohol, benzaldehyde, toluene, and phthalic acid
- resins notably gum benzoin. It is used largely for making its salts and esters, most notably sodium benzoate, which is widely used as a preservative in foods and beverages and as a mild antiseptic in mouthwashes and toothpastes.
- quinic acid refers to [lR-(l ⁇ ,3 ⁇ ,4 ⁇ ,5 ⁇ ]-l,3,4,5- Tetrahydroxycyclohexanecarboxylic acid.
- malic acid refers to hydroxybutanedioic acid.
- citric acid refers to citric acid or 2-hydroxy- 1,2,3 - propanetricarboxylic acid, H0 2 CCH 2 C(OH)(CO 2 H)CH 2 CO 2 H, an organic carboxylic acid containing three carboxyl groups. It is responsible for the tart taste of various fraits in which it occurs, e.g., lemons, limes, oranges, pineapples, and goosebenies.
- hippuric acid refers to N-Benzoylglycine.
- feralic acid refers to 3-(4-Hydroxy-3-methoxyphenyl)- 2-propenoic acid.
- chlorogenic acid refers to [lS-(l ⁇ ,3 ⁇ ,4 ⁇ ,5 ]-3-[[3- (3,4-Dihydroxyphenyl)-l -oxo-2-propenyl]oxy]- 1 ,4,5,trihydroxycyclohexanecarboxylic acid.
- carboxylic acid refers to 3-phenyl-2-propenoic acid.
- Betulinic acid can also be obtained from African Tree Uapaca nitida Mull-Arg (Euphorbiacea), leaves and bark o ⁇ Bacopa monniera( West Bengal), all species of Dilleniacea (Acrotrema arnothianum Wight, Dillenia andamanica Parkinson, D. aurea Smith, D. bracteata Wight, D. indica Linn, D. pentagina Roxb, D. retusa Thunb, D. scabtalla (D. Don) Roxb, ex Wall, Tetracera (Houtt. exChrism.& Panz., Men.), Tetracera akara (Burm.f.) Men., T. indica (Houtt.
- separating refers to the process of removing solids from a mixture.
- the process can employ any technique l ⁇ iown to those of skill in the art, e.g., decanting the mixture, filtering the solids from the mixture, or a combination thereof.
- filtering refers to the process of removing solids from a mixture by passing the liquid through a filter, thereby suspending the solids on the filter.
- aqueous base refers to a solution of water, and a substance that produces OH ions in the aqueous solution.
- the aqueous base can include water and at least one of a lithium ion (Li + ), a sodium ion (Na + ), a potassium ion (K + ), a calcium ion (Ca” + ), and a barium ion (Ba + ).
- the aqueous base can include water and at least one of sodium hydroxide (NaOH) and potassium hydroxide (KOH).
- alkaline metal refers to metals of Group IA of the
- the present invention employs a solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C.
- the solvent is water-immiscible.
- the solvent is capable of forming an azeotropic mixture with water.
- the solvent has a boiling point of at least 100°C.
- the solvent is water-immiscible and is capable of forming an azeotropic mixture with water.
- the solvent is water-immiscible and has a boiling point of at least 100°C.
- the solvent is capable of forming an azeotropic mixture with water and has a boiling point of at least 100°C.
- the solvent having a boiling point of at least 100°C can have a boiling point of at least about 120°C, at least about 140°C, or at least about 160°C. It is appreciated that those of skill in the art understand that the solvent should not chemically react with any of the starting materials or reagents present in the reaction mixture, to any significant degree, under the reaction conditions employed.
- water-immiscible solvent refers to a solvent that is not miscible (i.e., not capable of mixing in all proportions) with water.
- Suitable specific water-immiscible solvents include, e.g., aromatic hydrocarbons such as xylenes, oxylene, nt-xylene, ⁇ xylene, toluene, benzene, and combinations thereof; chlorinated solvents such as chloroform and methylene chloride; as well as other organic solvents such as ethyl-tert-butyl ether and ethyl acetate.
- water-miscible solvent refers to a solvent that is miscible (i.e., is capable of mixing in all proportions) with water. Suitable specific water-miscible solvents include, e.g., methanol, ethanol, z ' so-propanol, tert-butanol, ethylene glycol, acetone, 1-propanol and propylene glycol.
- distill or “distillation” refers to the process of extracting the volatile components of a mixture by the condensation and collection of the vapors that are produced as the mixture is heated. The process includes the evaporation and subsequent collection of a liquid by condensation.
- concentrating or “condensing” refers to the process whereby the volume is reduced, by the removal of liquid.
- mother liquor refers to the liquid obtained after solids are removed from a mixture or a solution of solids in a liquid. As such, the mother liquor will not include an appreciable amount of these solids.
- birch refers to any of the several deciduous trees of the genus Betula. The birches comprise the family Betulaceae in the order Fagales. Birch trees include, for example, white birch, B. alba; sweet, black or cheny birch, B. lenta; monarch birch, B.
- the birch can be B. alba, B. lenta, B. Maximowicziana, B. Nana, B. Platyphyla Japonica, B. Pubescens, B. alleghaniensis, B.
- birch bark refers to inner birch bark and outer birch bark.
- Inner birch bark is more dense and granular than outer birch bark, while outer birch bark is more flexible and fibrous than inner birch bark.
- Outer birch bark is light in color, thin (1-5 mm), tough, and of low water-content relative to inner birch bark. The inner bark is darker in color, thicker (3-10 mm) and non- fibrous relative to the outer bark.
- the inner bark is the portion of the tree wherein significant water transport occurs (i.e., an area of high water content). Due to the differences in the physical properties of inner birch bark and outer birch bark, fragmentation produces outer birch bark shreds and inner birch bark chunks. Outer birch bark shreds can be separated from the inner birch bark chunks using any suitable means. The separation can conveniently be accomplished by screening the mixture through a mesh having openings intermediate in size between the smaller inner bark chunks and the larger outer bark shreds. The smaller inner bark chunks fall through the screen and are separated from the outer bark.
- the “mesh” can be a unit comprising one or more open spaces in a cord, thread, or wire network in which the cords, threads or wires sunound the spaces.
- Any mesh suitable to separate inner birch bark from outer birch bark can be employed.
- the mesh is a wire mesh containing openings of about 54 of an inch by 54 of an inch, or smaller.
- mesh can conveniently contain openings of about 1/4 of an inch by about 1/4 of an inch.
- the size of the mesh can be about 20 mm by about 20 mm, or about 10 mm by about 10 mm, or about 6 mm by about 6 mm. More specifically, the size of the mesh can be about 3 mm by about 3 mm.
- the inner birch bark chunks and outer birch bark shreds may be separated with the use of an air classifier.
- an "air classifier” is a device which operates on the principle of the differing properties of the two components (e.g., imier and outer birch bark) in an air stream to effect a physical separation.
- the less dense outer bark travels a greater distance in the air stream than the more dense imier bark.
- the inner birch bark and the outer birch bark can be separated.
- outer birch bark of about 10 wt.%) to about 45 wt.% based on initial birch bark content is typically obtained and inner birch bark of about 55 wt.% to about 85 wt.% is typically obtained.
- birch bark shreds less than about 10 mm in diameter can conveniently be used. More specifically, outer birch bark shreds less than about 6 mm in diameter, less than about 4 mm in diameter, or less than about 2 mm in diameter, can be used.
- aromatic hydrocarbon refers to a compound having at least one phenyl or naphthyl ring, wherein the compound contains carbon and hydrogen atoms.
- the aromatic hydrocarbon can optionally be substituted, e.g., with one or more groups selected from the group of alkyl (e.g., methyl), hydroxyl, halo, alkoxy, cyano, carboxyl, sulfonyl, and amino.
- Suitable specific aromatic hydrocarbons include, e.g., xylenes, o-xylene, -xylene, p-xylene, toluene, benzene, and combinations thereof.
- "reflux” refers to the process of boiling a liquid in a vessel attached to a condenser so that the vapors continuously condense for reboiling.
- washing refers to the process of purifying a solid mass (e.g., crystals) by passing a liquid over and/or through the solid mass, as to remove soluble matter.
- the process includes passing a solvent, such as distilled water, over and/or through a precipitate obtained from filtering, decanting, or a combination thereof.
- a solvent such as distilled water
- washing includes contacting solids with water, vigorously stirring (e.g., for two hours), and filtering.
- the solvent can be water, can be an aqueous solvent system, or can be an organic solvent system.
- the washing can be ca ied out with the solvent having any suitable temperature.
- the washing can be carried out with the solvent having a temperature between about 0°C and about 100°C.
- a "binder" refers to a substance that can effectively bind
- Suitable binders useful in the present invention include, e.g., metal hydrides (e.g., lithium hydride (LiH), sodium hydride (NaH), potassium hydride (KH), calcium hydride (CaH ), and lithium aluminum hydride (LiAlH ); metal alcoholates (e.g., sodium methoxide (NaOMe), sodium ethoxide (NaOEt), potassium methoxide (KOMe), potassium ethoxide (KOEt), aluminum iso- propoxide [Al(i-OPr) 3 ], aluminum tert-butoxide [Al(t-OBu) 3 ], and aluminum methoxide [Al(OMe) 3 ]), ortho-esters (e.g., ethylorthocarbonate), dialkoxysulfates (e.g., dimethylsulfate and diethylsulfate), alumina and silica.
- metal hydrides e.g
- metal hydride refers to a binary compound of hydrogen and a metal. Suitable metal hydrides include e.g., lithium hydride (LiH), sodium hydride (NaH), potassium hydride (KH), calcium hydride (CaH 2 ), and lithium aluminum hydride (LiAlH ).
- metal alcoholate or “alcoholate” refers to an organic alcohol wherein the hydroxy hydrogen has been replaced with a metal, e.g., (CH CH 0) 3 A1.
- Aluminum alcoholates are suitable reagents for triterpene purification because it is believed that aluminum alcoholates bind strongly and ineversibly to acids and tannins, therefore providing complete discoloration of the total extract.
- Suitable specific metal alcoholates include, e.g., sodium methoxide (NaOMe), sodium ethoxide (NaOEt), potassium methoxide (KOMe), potassium ethoxide (KOEt), aluminum w ⁇ -propoxide [Al(i-OPr) 3 ], aluminum tert-butoxide [Al(t-OBu) 3 ], and aluminum methoxide [Al(OMe) ].
- “hydro lyze” or “hydrolysis” refers to the process of converting a carboxylic ester to the conesponding carboxylic acid, with the addition of water.
- the reaction i.e., hydrolysis
- the reaction can be canied out in a suitable solvent and at a suitable temperature and pressure, under basic conditions, neutral conditions, or acidic conditions.
- Suitable reagents and reaction conditions are disclosed, e.g., in Advanced Organic Chemistry, Part B: Reactions and Synthesis, Carey and Sundberg,
- the hydrolysis can be carried out at a pH of greater than about 7.0 (e.g., a pH of about 7-8, 8-9, 9-10, 10-11, or 11-12).
- Suitable bases include metal hydroxides and metal alkoxides.
- Suitable metal hydroxides include sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide and barium hydroxide.
- Suitable metal alkoxides include lithium methoxide, lithium ethoxide, lithium isopropoxide, lithium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium tert-butoxide, potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, magnesium methoxide, magnesium ethoxide, barium methoxide, barium ethoxide, calcium methoxide and calcium ethoxide.
- a specific base suitable for the processes of the present invention i.e., hydrolysis of birch bark
- the hydrolysis can be carried out at a pH of less than about
- 7.0 e.g., a pH of about 1-2, 2-3, 3-4, 4-5, 5-6, or 6-7.
- suitable acids include, for example, hydrochloric acid, phosphoric acid, formic acid, hydi'obromic acid, sulfuric acid, nitric acid, acetic acid, and combinations thereof.
- a specific acid suitable for the processes of the present invention i.e., hydrolysis of birch bark
- the hydrolysis can be earned out at a pH of about 6.5 to about 7.5 (i.e., neutral conditions).
- natural ester refers to an organic compound (e.g., triterpenes or triterpenoids) having at least one carboxylic ester group.
- azeotropic distillation refers to the process of boiling off or distilling any liquid mixture having constant minimum and maximum boiling points and distilling off without decomposition and in a fixed ratio, as with benzene and water, or as with toluene and water.
- the azeotropic distillation can include the co -distillation of water and at least one of xylenes, oxylene, -xylene, p-xy ⁇ ene, toluene, and benzene.
- a distillation can be canied out at a temperature and a period of time, effective to distill or boil more than about 90% of the water, more than about 95% of the water, more than about 98% of the water, or up to about 100 wt.% of the water.
- azeotropic mixture refers to a mixture which would undergo azeotropic distillation.
- agitating refers to the process of putting a mixture into motion with a turbulent force. Suitable methods of agitating include, e.g., stining, mixing, and shaking.
- precipitating refers to the process of causing a solid substance (e.g., crystals) to be separated from a solution.
- the precipitating can include, e.g., crystallizing.
- polar organic solvent refers to an organic solvent having a measurable dipole. Specifically, it refers to an organic solvent having a dielectric constant of at least about 15, at least about 20, or between about 20 and about 30.
- non-polar organic solvent refers to an organic solvent having no measurable dipole. Specifically, it refers to an organic solvent having a dielectric constant of less than about 15, less than about 10, or between about 6 and about 10.
- drying refers to the removal of water and/or solvent, such that the water and/or solvent content is below about 5 wt.%, below about 2 wt.% or below about 1 wt.%.
- neutralizing refers to the process of changing or bringing the pH to about 7 ⁇ 1.
- the neutralizing can include bringing the pH to about 6 to about 8.
- the neutralizing can include bringing the pH to about 6.5 to about 7.5 (i.e., to a pH of about 7 ⁇ 0.5).
- the neutralizing can include bringing the pH to about 6.75 to about 7.25 (i.e., to a pH of about 7 ⁇ 0.25).
- acidifying refers to the process of lowering the pH to below 7.0.
- the acidifying includes lowering the pH to below about 6.0.
- the acidifying includes lowering the pH to below about 5.0.
- the acidifying includes lowering the pH to below about 4.0.
- purifying refers to the process of ridding a solid substrate (e.g., crystals) of impurities. Suitable methods of purifying include, e.g., washing, recrystallizing and drying. In cases where compounds are sufficiently basic or acidic to form stable nontoxic acid or base salts, administration of the compounds as salts maybe appropriate.
- Examples of pharmaceutically acceptable salts are organic acid addition salts formed with acids, which form a physiological acceptable anion, for example, tosylate, methanesulfonate, acetate, citrate, malonate, tartarate, succinate, benzoate, ascorbate, ⁇ -ketoglutarate, and oglycerophosphate.
- a physiological acceptable anion for example, tosylate, methanesulfonate, acetate, citrate, malonate, tartarate, succinate, benzoate, ascorbate, ⁇ -ketoglutarate, and oglycerophosphate.
- Suitable inorganic salts may also be formed, including hydrochloride, sulfate, nitrate, bicarbonate, and carbonate salts.
- Pharmaceutically acceptable salts may be obtained using standard procedures well known in the art, for example by reacting a sufficiently basic compound such as an amine with a suitable acid affording a physiologically acceptable anion.
- Alkali metal (for example, sodium, potassium or lithium) or alkaline earth metal (for example calcium) salts of carboxylic acids can also be made.
- compositions that include a compound obtained by the processes described herein can be fonnulated as pharmaceutical compositions and/or cosmetic compositions, and administered to a mammalian host, such as a human patient in a variety of forms adapted to the chosen route of administration, i.e., orally or parenterally, by intravenous, intramuscular, topical or subcutaneous routes.
- a mammalian host such as a human patient
- the present compositions can be systemically administered, e.g., orally, in combination with a pham aceutically acceptable vehicle such as an inert diluent or an assimilable edible canier. They may be enclosed in hard or soft shell gelatin capsules, may be compressed into tablets, or may be incorporated directly with the food of the patient's diet.
- compositions may be combined with one or more excipients and used in the form of ingestible tablets, buccal tablets, troches, capsules, elixirs, suspensions, syrups, wafers, and the like.
- excipients for oral therapeutic administration, the compositions may be combined with one or more excipients and used in the form of ingestible tablets, buccal tablets, troches, capsules, elixirs, suspensions, syrups, wafers, and the like.
- Such preparations should contain at least 0.1 % of the triterpene compound.
- the percentage of the compositions can, of course, be varied and may conveniently be between about 2 to about 60%) of the weight of a given unit dosage form.
- the amount of active compound (i.e., triterpene compound) in such therapeutically useful compositions is such that an effective dosage level will be obtained.
- the tablets, troches, pills, capsules, and the like may also contain the following: binders such as gum tragacanth, acacia, corn starch or gelatin; excipients such as dicalcium phosphate; a disintegrating agent such as com starch, potato starch, alginic acid and the like; a lubricant such as magnesium stearate; and a sweetening agent such as sucrose, fructose, lactose or aspartame or a flavoring agent such as peppermint, oil of wintergreen, or cheny flavoring may be added.
- a liquid canier such as a vegetable oil or a polyethylene glycol.
- any material used in preparing any unit dosage form should be pharmaceutically acceptable and substantially non-toxic in the amounts employed.
- the active compound i.e., triterpene
- the active compound may be incorporated into sustained-release preparations and devices.
- compositions may also be administered intravenously or intraperitoneally by infusion or injection.
- Solutions of the triterpene can be prepared in water, optionally mixed with a nontoxic surfactant.
- Dispersions can also be prepared in glycerol, liquid polyethylene glycols, triacetin, and mixtures thereof and in oils. Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms.
- the pharmaceutical dosage forms suitable for injection or infusion can include sterile aqueous solutions or dispersions or sterile powders comprising the active ingredient, which are adapted for the extemporaneous preparation of sterile injectable or infusible solutions or dispersions, optionally encapsulated in liposomes.
- the liquid canier or vehicle can be a solvent or liquid dispersion medium comprising, for example, water, ethanol, a polyol (for example, glycerol, propylene glycol, liquid polyethylene glycols, and the like), vegetable oils, nontoxic glyceryl esters, and suitable mixtures thereof.
- the proper fluidity can be maintained, for example, by the formation of liposomes, by the maintenance of the required particle size in the case of dispersions or by the use of surfactants.
- the prevention of the action of microorganisms can be brought about by various antibacterial and antifungal agents, for example, parabens, chlorobutanol, phenol, sorbic acid, thimerosal, and the like.
- isotonic agents for example, sugars, buffers or sodium chloride.
- Prolonged absorption of the injectable compositions can be brought about by the use in the compositions of agents delaying absorption, for example, aluminum monostearate and gelatin.
- Sterile injectable solutions are prepared by incorporating the triterpene in the required amount in the appropriate solvent with various of the other ingredients enumerated above, as required, followed by filter sterilization.
- the prefened methods of preparation are vacuum drying and the freeze-drying techniques, which yield a powder of the triterpene, plus any additional desired ingredient present in the previously sterile-filtered solutions.
- the present compositions may be applied in pure form, i.e., when they are liquids. However, it will generally be desirable to administer them to the skin as compositions or formulations, in combination with a dermatologically acceptable canier, which may be a solid or a liquid.
- a dermatologically acceptable canier which may be a solid or a liquid.
- Useful solid carriers include finely divided solids such as talc, clay, microcrystalline cellulose, silica, alumina and the like.
- Useful liquid carriers include water, alcohols or glycols or water-alcohol/glycol blends, in which the triterpene can be dissolved or dispersed at effective levels, optionally with the aid of non-toxic surfactants.
- Adjuvants such as fragrances and additional antimicrobial agents can be added to optimize the properties for a given use.
- the resultant liquid compositions can be applied from absorbent pads, used to impregnate bandages and other dressings, or sprayed onto the affected area using pump-type or aerosol sprayers.
- Thickeners such as synthetic polymers, fatty acids, fatty acid salts and esters, fatty alcohols, modified celluloses or modified mineral materials can also be employed with liquid caniers to form spreadable pastes, gels, ointments, soaps, and the like, for application directly to the skin of the user.
- useful dermatological compositions which can be used to deliver the compositions of the triterpene, to the skin, are known to the art; for example, see Jacquet et al. (U.S. Pat. No. 4,608,392), Geria (U.S. Pat. No. 4,992,478), Smith et al. (U.S. Pat. No. 4,559,157) and Wortzman (U.S. Pat. No.
- compositions of the triterpene can be determined by comparing their in vitro activity, and in vivo activity in animal models. Methods for the extrapolation of effective dosages in mice, and other animals, to humans are known to the art; for example, see U.S. Pat. No. 4,938,949.
- concentration of the compositions of the triterpene in a liquid composition, such as a lotion will be from about 0.1-25 wt-%, preferably from about 0.5-10 wt-%.
- concentration in a semi-solid or solid composition such as a gel or a powder will be about 0.1-5 wt-%, preferably about 0.5-2.5 wt- %.
- a suitable dose will be in the range of from about 0.5 to about 100 mg/kg, e.g., from about 10 to about 75 mg/kg of body weight per day, such as 3 to about 50 mg per kilogram body weight of the recipient per day, preferably in the range of 6 to 90 mg/kg/day, most preferably in the range of 15 to 60 mg/kg/day.
- the composition is conveniently administered in unit dosage form; for example, containing 5 to 1000 mg, conveniently 10 to 750 mg, most conveniently, 50 to 500 mg of triterpene per unit dosage form.
- the composition should be administered to achieve peak plasma concentrations of the triterpene of from about 0.5 to about 75 ⁇ M, preferably, about 1 to 50 ⁇ M, most preferably, about 2 to about 30 ⁇ M. This maybe achieved, for example, by the intravenous injection of a 0.05 to 5% solution of the triterpene, optionally in saline, or orally administered as a bolus containing about 1-100 mg of the triterpene.
- Desirable blood levels may be maintained by continuous infusion to provide about 0.01-5.0 mg/kg/hr or by intermittent infusions containing about 0.4-15 mg/kg of the triterpene(s).
- the desired dose may conveniently be presented in a single dose or as divided doses administered at appropriate intervals, for example, as two, three, four or more sub-doses per day.
- the sub-dose itself may be further divided, e.g., into a number of discrete loosely spaced administrations; such as multiple inhalations from an insufflator or by application of a plurality of drops into the eye.
- compositions of the invention may be determined using pharmacological models which are well known to the art.
- the compositions of the invention maybe also be useful as pharmacological tools for the further investigation of the mechanism of their anti-fungal, anti-bacterial, and/or anti- viral action.
- the compositions of the invention can also be administered in combination with other therapeutic agents that are effective to treat, e.g., fungal infections, bacterial infections, and/or viral infections; or to inhibit or kill a fungus, bacterium, and/or virus.
- the processing includes extracting (3) outer birch bark (2) with an organic solvent to provide a birch bark extract (4).
- Suitable solvents, techniques and conditions for the extracting (3) are known to those of skill in the art.
- the extracting (3) will preferably employ suitable solvent(s) in which the desired compound(s) are relatively soluble.
- the extracting (3) can be canied out under conditions (e.g., temperature, pressure and period of time), effective to extract the desired compound(s) in a relatively high yield, while minimizing any decomposition of the desired compound(s).
- the extracting (3) effectively provides birch bark extract (4), which can subsequently be refluxed (21) with a metal hydroxide (5), distilled (6), and filtered/decanted (7), to provide the solids (8) and filtrate (9).
- the refluxing (21) of the birch bark extract (4) with the metal hydroxide (5) can be carried out under conditions (e.g., temperature and period of time) and with reagents and solvents, effective to reflux (21) the reaction mixture, while minimizing any decomposition of the desired compound(s).
- Suitable metal hydroxides (5) are l ⁇ iown to those of skill in the art.
- the reaction mixture can then be distilled (6), to effectively remove water present in the reaction mixture.
- This distillation (6) will remove not only water, but also a discrete amount or organic solvent (e.g., xylenes, toluene and/or benzene) present in the reaction mixture.
- the distillation (6) will also not remove any appreciable amounts of metal hydroxides (5) along with the water. Additionally, no appreciable amounts of triterpenes or triterpenoids are removed with the water during the distillation (6).
- the metal hydroxide reacts with acids (e.g., triterpenoid acids) while in solution, to provide the conesponding salts. These salts are relatively insoluble in the organic solvent employed. As such, the salts will precipitate from the solution after removal of the water during the distillation (6).
- the solids (8) which can be visible as a black tar, precipitates from solution, and can subsequently be separated (e.g., filtered or decanted (7)) from solution to provide the solid (8) and filtrate (9).
- the solid (8) contains betulinic acid (15), and can be purified accordingly.
- the filtrate (9) can be treated with binder (25) to provide a mixture.
- the mixture can be filtered (27) to provide a second filtrate.
- the second filtrate can be concentrated (29), and crystallized (30), to provide betulin (17) and a filtrate (16).
- This filtrate (16) can be concentrated (31), washed (33), crystallized (35), concentrated (36) and crystallized (37) to provide lupeol (20).
- the solid (8) described above can be washed with water (38), neutralized/acidified (10), filtered/decanted (11), and subsequently crystallized (12) to provide betulinic acid (15).
- plant matter processing (100) utilizing distillation (106) is illustrated.
- Plant matter (101) can be purified, to provide acidic components of plant mater extract (117) and non-acidic components of plant matter extract (120).
- the plat matter (101) is extracted (102) to provide plant matter extract (103).
- the plant matter extract (103) can b e refluxed with a metal hydroxide (105), distilled (106), and filtered/decanted (107), to provide solids (108) and filtrate (109).
- the solids (108) can be washed (130), neutralized/acidified (110), filtered/decanted (111), and crystallized (112), to provide acidic components of plant matter extract (117).
- the filtrate (109) can be contacted with binder (131), filtered (132), concentrated (113), and crystallized (114), to provide filtrate (115) and non-acidic component of plant matter extract (116).
- the filtrate (115) can be concentrated (140), washed (141), and crystallized (142) to provide non-acidic component of plant matter extract (120).
- Example 1 Extraction of outer birch bark with xylenes Air-dry pellets of outer birch bark (200 g) were extracted with p-xylene (1 x 1 L) and then with p-xylene (3 x 300ml). Each time the extraction mixture was refluxed for 20 min and then filtered at 90°C. The solvent of the combined organic extracts was evaporated and the residue was dried at 80°C, in vacuum, to give 44 g (yield is 22 wt.%>) of dry birch bark extract. The p-xylene extract was used without further purification.
- Example 2 Isolation of betulin
- the birch bark extract (44 g) obtained from the procedure in Example 1 was dissolved in xylenes (1.1 L) at 80°C.
- Sodium hydroxide (NaOH) (8.8g) was dissolved in 80°C water (17.4 ml).
- the two mixtures were combined, vigorously stined and refluxed for 1 hr.
- Water (17.4 ml) was removed from the reaction mixture by azeotropic distillation on a Dean-Stark trap, and the reaction mixture was filtered to remove the black tar that precipitated from solution.
- This black tar includes the crude sodium salts of triterpenoid acids (19.8 g), including betulinic acid, as shown in Example 4 below.
- Example 3 Isolation of lupeol
- the mother liquid from Example 2 was evaporated to afford 11 g (25 %) of crade lupeol / betulin mixture. 20 ml of acetone was added to this mixture, stined at 60°C for one hour and cooled down 5-10°C for two hours. The yellowish precipitate (4.5 g) was filtered and crystallized from xylene. The mother liquid after xylene filtering was removed and the yellowish solid crystals of lupeol were crystalyzed from cyclohexane.
- Example 5 Azeotropic distillation sing sodium hydroxide, water and xylenes A solution of NaOH (90g) in 180 ml of water was added to the vigorously stined solution of birch bark extract in xylenes* (13.5 L) at 90°C.
- the stined solution was kept at 100°C for 1 hour. Azeotropic mixture of water and xylenes (total volume 4.0 L) was distilled (xylene recycling). The xylenes solution (9.5 L) was then filtered at 90-100°C into the heated up to 100°C reactor and transfened to example 7. The black solid product was dried at 80°C for 5 hours in vacuum. This product (196g) was transfened to example 9 for betulinic acid separation and purification. * - The cheapest Xylene isomers mixture can be used for this purpose
- Example 6 Azeotropic Distillation A solution of KOH (126g in 180 ml of water) was added to the ⁇ vigorously stined solution of birch bark extract (456 g in 13.5 L of xylenes*) at 90°C. The stined solution was kept at 100°C for 1 hour. Azeotropic mixture of water and xylenes (total volume 4.0 L) was removed (xylene recycling). The solution was then filtered at 90-100°C. The black solid product was transfened from filter and dried at 80°C for 5 hours in vacuum. This product (221 g) was transfened to example 9 for betulinic acid separation and purification. * - The cheapest Xylene isomers mixture may be used for this purpose (Aldrich 24,764-2; 18 L, $93.80)
- Example 7 Treatment with Dimethyl Sulfate and crystallization Recycled betulin (33 g) and 18.0 g of K2CO3 were added to the stined hot filtrate of treated with NaOH birch bark extract (350 g) in xylenes (9.5 L) (xylenes solution from example 5). This mixture was stined for 10 minutes at 100°C. Dimethyl sulfate (12 ml) was added and the resulting mixture was stined for 2 hrs. Then 180 ml of water was added and mixture was stined at 100°C for 0.5 hour. Xylenes (5.5 L) and water (170 ml) were removed by azeotropic distillation.
- Example 8 Lupeol separation and betulin recycling Xylenes were evaporated from and the filtrate solution (the filtrate solution from example 7). Acetone (0.5 L) was then added and the mixture was vigorously stined and refluxed for 1 hr. Then acetone solution was cooled down to room temperature and filtered. Operation with acetone was repeated three times. White solid material (83 g) after washing with acetone was dried and crystallized from 1.8 L of xylene. After filtration 37 g of solid white material (75% of betulin and 10% of lupeol, 15% others) was received and used in Example 7 as recycling betulin product.
- the yield of lupeol is 0.47% calculated from starting outer birch bark. Combined acetone mother liqueurs were evaporated. Yellow solid (27.6 g) product (50% of lupeol) was obtained and can be used for lupeol separation in recycling process.
- Example 9 Betulinic acid separation and purification Dry black solid product from step 1 (196 g) was stined in 3.5 L of water and filtered. This operation was repeated two times using 1 L of water each time. A solution of 2% HCl (0.8 L) was then added to a suspension of solid product in 250 ml of water and stined for 0.5 hours, filtered. Solid product was then washed with water (2x200 ml) and dried at 40°C for 5 hours in vacuum drier to give 32 g of crade betulinic acid.
- Crade betulinic acid (32 g) was dissolved in 0.95 L of refluxed 2- propanol, filtered and evaporated to 300 ml, and left for crystallization at 35°C for 5 hours. Precipitate was filtered at 35°C and dried at 40°C for 5 hours in vacuum drier to give 17.6 g of crade betulinic acid.
- Cmde betulinic acid (17.6 g) was refluxed with 500 ml of 2-propanol and filtered. 2-Propanol was evaporated to volume of 170 ml. After crystallization at room temperature white crystals were filtered and 15.5 g of betulinic acid (92 %>+ purity) was obtained.
- Betulinic acid (15.5 g) was dissolved in 500 ml of refluxed xylenes and a solution of NaOH (5 g) in 10 ml of water was added. This solution was refluxed with a good stining for 1 hour. Xylenes and water (total volume is 90 ml) were removed by azeotropic distillation from reaction mixture. Sodium salt of betulinic acid was filtered on hot filter and dried at 80oC for 3 hours. White solid product was then added into water (50 ml) and a 1% solution (200 ml) of HCl in water was added dropwise, and stined for 0.5 hour, filtered, washed with water (2x50 ml) and dried. 14 g of betulinic acid (98%) purity) was obtained. The yield of betulinic acid from starting outer birch bark was 0.7%.
- Example 10 Betulin separation from birch bark extract
- Raw Material Amount Birch Bark pellets 100 g Xylenes 1065 ml KOH 6.125 g Water 8.75 ml Celite 521 (Aldrich) 20 g Aluminum Oxide (basic) 2.5 g
- the approximate expected retention time for Betulinic Acid is 7.7 minutes. Specificity is determined by an analysis of the diluent blank sample. Specificity of the instrument is acceptable when there is no interference of the blank sample with quantitation of the target sample. In order to test the linearity of the relationship between the target sample and concentration, five standards are prepared covering the range of 10-120% of the 50 ⁇ g/mL target concentration for Betulinic Acid. The peak area response versus concentration is evaluated by linear regression. The slope, intercept and residual sum of squares are reported to provide a linear conelation of not less than 0.99 (1 being perfectly linear). The sensitivity samples have target concentrations of 12.5 ⁇ g/mL and 5 ⁇ g/mL Betulinic Acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
The present invention provides a method for obtaining a natural product (e.g., betulin, lupeol and/or betulinic acid) from a plant extract (e.g., birch bark extract). The method employs a distillation with water and an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., toluene) and an aqueous base (e.g., KOH).
Description
METHOD FOR OBTAINING NATURAL PRODUCTS FROM PLANT MATERIAL
Background of the Invention Birch bark is a low-value waste product in the forest industry today. Ekman, R., Holzforschung, (1983) 37, 205. Approximately 230,000 tons of birch bark are generated per year. For example, a single paper mill can generate 70 tons of birch bark per day. Thus, vast quantities of birch bark and its chemical components are available. Birch bark is a potential source of a variety of organic chemicals. Several triterpenoids have been identified in birch bark extracts. For example, lupeol, betulin, betulinic aldehyde, betulinic acid, methyl betulinate, lupenone, betulonic aldehyde, betulonic acid, /3-amyrin, erythiOdiol, oleanolic aldehyde, oleanolic acid, methyl leanolate and acetyl oleanolic acid are all present in the outer bark oϊBetula verrucosa. Eckerman, C, (1985) Paperi ja Puu, No. 3, 100. hi addition, several suberinic acids isolated from birch bark, as well as several triterpenoids, have been identified in the bark oϊBetula verrucosa. Ekman, R., Holzforschung, (1983) 37, 205. The chemical constituents of birch bark are useful in pharmaceutical and industrial applications. For example, U.S. Pat. No. 5,750,578 discloses that betulin possesses antiviral properties and is useful to treat herpes virus. Betulin also possesses anti-feedant activity against boll weevils, and anti-inflammatory activity (Miles, D. H., 1994, J. Agric. Food. Chem., 42, 1561-1562 and Recio, M., PlantaMed., 1995, 61, 9-12. hi addition, betulin showed cough suppressant and expectorant effects. Jinuhua, W., Zhongguo Yaoxue Zazhi, (1994), 29(5), 268-71. Betulin is also a useful starting material for preparing alobetulin and derivatives thereof, which posses useful pharmacological properties. Betulin can be converted to betulinic acid, which is useful as a therapeutic agent. For example, Pisha, E. et al., (1995) J. M. Nature Medicine, 1,
1046-1051 discloses that betulinic acid has anti-tumor activity against human melanoma, e.g., MEL-1, MEL-2 and MEL-4. hi addition, Fujioka, T. et al, J.
Nat. Prod.. (1994) 57, 243-247 discloses that betulinic acid has anti-HIV activity in H9 lymphocytic cells. Current methods for isolating the chemical constituents of birch bark are deficient in several ways. For example, betulin has been extracted from the bark of white-barked birches in amounts up to 20%, based on the dry weight of the bark. Elkman, R., (1983) Holzforsch, 37, 205; Ohara, S., et al., (1986) Mokuza Gakkaishi, 32, 266. In addition, betulm has been isolated from outer birch bark waste oϊBetula verrucosa by liquid extraction employing boiling organic solvents and subsequent recrystallization. Eckerman, C, (1985) Paperi ja Puu, No. 3, 100. While current processes afford acceptable yields of betulm (e.g., 11- 20%), these processes suffer from several major drawbacks. Specifically, the current methods employed to isolate not only betulin, but other components in birch bark (e.g., lupeol and betulinic acid) are costly, inefficient an/or are unsafe. Russian Patent Nos. RU2175326 (publication date 27 October 2001) and RU2192879 (publication date 20 November 2002), discloses methods of preparing betulin, and derivatives thereof. The methods disclosed in Russian Patent No. RU2192879 include birch bark milling, separation of birch bark fibers, extraction of birch bark, separation of solution from extracted birch bark, and solvent removal from solution. The birch bark extraction is carried out with toluene at temperature of 90°C-110°C for 1.5-3.0 h, and the solution is filtered at a temperature of 40°C-50°C. The toluene betulin solution is cooled for 6-10 h to a temperature of 15°C - 5°C. Published U.S. Patent Application US 2003/0153776 Al ("the '776 patent application), assigned to Boehringer Ingelheim Pharma, discloses a process for obtaining betulin from birch bark (see Abstract). The process includes extracting birch bark with a high-boiling, water-immiscible solvent, and extracting this extract with a dilute aqueous base (see claim 1). The methods in the '776 patent application are disclosed to provide betulin. No other triterpenoids (e.g., lupeol, betulinic acid, or a combination thereof) are obtained with the methods described therein. Additionally, only 4 wt.% of betulin is obtained with the methods described therein. The use of charcoal is also required in the methods described therein. It is believed that the use of a decolorization agent such as activated charcoal decreases the overall yield of
betulin. The methods described in the '776 patent application are not able to effectively remove triterpenoids such as betulin-3-caffeate, betulinic acid, lupeol, esters of fatty acids, fatty acids, polyphenols and tannins, from the birch bark or birch bark extract. The process described in the '776 patent application is unsuitable for the industrial scale recovery of betulin, as well as lupeol and betulinic acid. The yields and purities of betulin disclosed in the '776 patent application are believed to be erroneous, utilizing the processes described therein. Even if accurate, the yields and purities of betulin disclosed in the '776 patent application can be improved. The processes described therein cannot be practiced on larger, industrial scales (e.g., kilograms or tons). A need therefore exists for safer, more cost-efficient and/or more efficient methods to obtain commercial quantities (e.g., tons) of betulin; as well as commercial quantities (e.g., kg) of lupeol and betulinic acid from birch bark. Summary of the Invention The process of the present invention is suitable for obtaining betulin, lupeol and betulinic acid from birch bark, in a yield of about 10 wt.% to about 12 wt.%, about 2.5 wt.% and about 2 wt.%, respectively. The betulin, lupeol and betulinic acid obtained using the methods of the present invention are relatively pure. For example, the betulin will typically include less than about 0.02 wt.% of betulinic acid. Additionally, employing methods of the present invention, commercial quantities (e.g., tons) of betulin; as well as commercial quantities (e.g., kg) of lupeol and betulinic acid can be obtained from birch bark. The methods of the present invention can also be employed to effectively remove betulin-3-caffeate, betulinic acid, esters of fatty acids, fatty acids, polyphenols and tannins from the birch bark or birch bark extract. Specifically, betulin-3-caffeate and esters of fatty acids are effectively hydro lyzed upon contact and heating with the base. Upon hydrolysis, the betulin-3-caffeate is converted to betulin, which increases the overall yield of betulin; and the esters of fatty acids provide methanol and a salt of betulinic acid, which precipitates and can be removed from the reaction mixture. The betulinic acid precipitates as a basic salt, and can be removed from the reaction mixture. The polyphenols also precipitate as polyphenolates, which can be removed from the reaction mixture.
The present invention provides a method for obtaining a natural product from plant material. The method includes: (a) contacting plant material with a solvent to provide a first mixture; (b) separating the plant material from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; and (f) concentrating the fourth mixture, or precipitating solids from the fourth mixture, to provide a natural product. The present invention also provides a method for selectively obtaining one or more non-acidic compounds from plant tissue in the presence of one or more acidic compounds. The method includes: (a) contacting plant material with a solvent to provide a first mixture; (b) separating the plant material from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; and (f) concentrating the fourth mixture, or precipitating solids from the fourth mixture, to provide a natural product. The present invention also provides a method for obtaining betulin from birch bark. The method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or
(iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about
140°C, or at least about 160°C), effective to distill off water present in the second
mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; (f) contacting the fourth mixture with binder to provide a fifth mixture; (g) filtering the fifth mixture to provide a solution; (h) concentrating the solution to provide betulin, or precipitating betulm from the solution. The present invention also provides a method for obtaining lupeol from birch bark. The method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; (f) precipitating solids from the fourth mixture; (g) separating the solids from the fourth mixture to provide a mother liquor; (h) concentrating the mother liquor to provide a fifth mixture; (i) washing the fifth mixture with a polar organic solvent to provide a sixth mixture; (j) crystallizing the sixth mixture with a non-polar organic solvent to provide a solution; (k) concentrating the solution to provide crude lupeol. The process can optionally further include (1) recrystallizing the lupeol from a polar organic solvent to provide pure lupeol and (m) drying the pure lupeol. The present invention also provides a method for obtaining betulinic acid from birch bark. The method includes: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture; (f) washing the solid with water to provide a second solids; (g) neutralizing or acidifying the second solids with an aqueous acid,
thereby providing a fourth mixture; (h) separating crude betulinic acid from the fourth mixture. The process can optionally further include (i) crystallizing the crude betulinic acid from polar organic solvent to provide pure betulinic acid and (j) drying the pure betulinic acid. The present invention also provides a method for purifying an extract of a natural product. The method includes: (i) contacting an extract of a natural product with an aqueous base, to provide a first mixture; (ii) heating the first mixture in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present in the first mixture, thereby providing a second mixture; (iii) separating solids from the second mixture, to provide a third mixture; and (iv) concentrating the third mixture or precipitating solids from the third mixture, to provide a pμrified natural product. '' The contacting of the extract with an aqueous base and heating in an organic solvent that (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C (e.g., at least about 120°C, at least about 140°C, or at least about 160°C), effective to distill off water present, can specifically include azeotropic distillation. The present invention also provides a compound obtained from the method of the present invention. The present invention also provides a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a compound obtained from the method of the present invention. The present invention also provides a cosmetic composition that includes a cosmetically acceptable carrier and a compound obtained from the method of the present invention. Brief Description of the Figures Embodiments of the invention may be best understood by referring to the following description and accompanying drawings which illustrate such embodiments. The numbering scheme for the Figures included herein are such that the leading number for a given reference number in a Figure is associated with the number of the Figure. Reference numbers are the same for those
elements that are the same across different Figures. For example, a block flow diagram depicting outer birch bark (2) can be located in Figure 1. However, reference numbers are the same for those elements that are the same across different Figures. In the drawings: Figure 1 illustrates a block flow diagram depicting the isolation of betulin, lupeopl, and/or betulinic acid from birch bark, employing distillation. Figure 2 illustrates a block flow diagram depicting the isolation of acidic components (natural products) and non-acidic components (natural products) from plant material, employing distillation. Detailed Description of the Invention Specific values listed below for ranges are for illustration only; they do not exclude other defined values or other values within defined ranges.
Definitions As used herein, "triterpene" or "triterpenoid" refers to a plant secondary metabolite that includes a hydrocarbon, or its oxygenated analog, that is derived from squalene by a sequence of straightforward cyclizations, functionalizations, and sometimes rean-angement. Triterpenes or analogues thereof can be prepared by methods known in the art, i.e., using conventional synthetic techniques or by isolation from plants. Suitable exemplary triterpenes and the biological
"synthesis of the same are disclosed, e.g., in R.B. Herbert, The Biosynthesis of Secondary Plant Metabolites, 2nd. Ed. (London: Chapman 1989). The tem "triterpene" refers to one of a class of compounds having approximately 30 carbon atoms and synthesized from six isoprene units in plants and other organisms. Triterpenes consist of carbon, hydrogen, and optionally oxygen. Most triterpenes are secondary metabolites in plants. Most, but not all, triterpenes are pentacyclic. Examples of triterpenes include betulin, allobetulin, lupeol, friedelin, and all sterols, including lanosterol, stigmasterol, cholesterol, jS-sitosterol, and ergosterol. As used herein, "betulin" refers to 3/3,28-dihydroxy-lup-20(29)-ene.
Betulin is a pentacyclic triterpenoid derived from the outer bark of paper birch trees (Betula papyrifera, B. pendula, B. verucosa, etc.). It can be present at
concentrations of up to about 24% of the bark of white birch. Merck Index, twelfth edition, page 1236 (1996). Stmcturally, betulin is shown below:
As used herein, "betulinic acid" refers to 9-hydroxy-l-isopropenyl- 5a,5b,8,8,l la-pentamethyl-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid. Structurally, betulinic acid is shown below:
As used herein, "lupeol" refers to lup-20 (29)-en-3 /3-ol. Lupeol is also found in birch bark and in other plant sources. Lupeol is present at concentrations of about 1.5-3% of the birch bark and at up to about 8.2% in Canavalia ensifomiis, a plant widespread in the humid tropics of Asia and Africa. Structurally, lupeol is shown below:
As used herein, "natural product" refers to naturally occurring compounds that are end products of secondary metabolism; often, they are unique compounds for particular plants or species of plants. In a specific embodiment of the present invention, the compounds can be derived from plant material, e.g., birch bark. Such compounds can include, e.g., triterpenes or triterpenoids. Additionally, the natural product can include a single compound, or can include one or more different compounds. Additionally, these one or more different compounds can be structurally related or stmcturally unrelated. As used herein, a "non-acidic compound" refers to a natural product that comprises lupeol, betulin, taxol, paclitaxel, echinacea extract, valerian root extract, ginkgolide A, ginkgolide B, ginlcgolide C, bilobalide, garlic extract, ginseng extract, aloe gel, barbaloin, cranbeny extract, eleutheroside A, eleutheroside B, eleutheroside C, eleutheroside D, eleutheroside E, eleutheroside
G, kava extract, dill seed oil, kola extract, quinoline alkoloids, or a combination thereof.
As used herein, an "acidic compound" refers to a natural product that acidic compounds comprises betulin acid, betulin-3-caffeate, tannin, lipid, phenol, caffeic acid, cichoric acid, valerenic acid, isovaleric acid, flavonoid, quercetin, kaempferol, catechin, lignin, shikimic acid, succinic acid, amino acid, nicotinic acid, pantothenic acid, anthraquinone, acidic galactan, benzoic acid, quinic acid, malic acid, citric acid, hippuric acid, phenolic acid, feralic acid, . chlorogenic acid, norsolorinic acid, or a combination thereof. As used herein, "plant material" or "plant tissue" refers to a collection of similar cells of a plant, that typically act together to perform a particular function. The term refers to the tissue of any organism of the plant kingdom, as opposed to one of the animal kingdom or of the kingdoms of Fungi, Protista, or Monera. The plant tissue can be any portion or portions of the plant (e.g., bark, roots, leaves, flowers, needles, bulbs, benies, rhizomes, rootstocks, stems, and seeds), as well as the entire plant. The tissues of a plant ("plant tissue") generally fall into three main categories: dermal tissue, ground tissue, and vascular tissue. Dermal tissue refers to the "skin" layer of all plant organs and is responsible for environmental interaction (light passage, gas exchange, pathogen recognition and protection, color display, etc.). Demial tissue is composed of epidermal cells, closely packed cells that secrete a waxy cuticle that aids in the prevention of water loss. Ground tissue lies between dermal tissue and vascular tissue. The ground tissue comprises the bulk of the primary plant body. Parenchyma, collenchyma, and sclerenchyma cells are common in the ground tissue, h roots, the ground tissue may store sugars or starches to fuel the spring sap flow; in leaves, the ground tissue is the layer responsible for photosynthesis (the mesophyll). Vascular tissue transports food, water, hormones and minerals within the plant. Vascular tissue includes xylem, phloem, parenchyma, and cambium cells. As used herein, "bark" refers to the dry, dead outer covering of woody branches, stems and roots of plants that is very distinct and separable from the wood itself. It includes all tissue outside the cambium (growth layer between bark and wood). As used here the terms "leaf or "leaves" refer to those parts of a plant which grow along the sides of branches or stems or at the bases of plants. Most
are green and contain chlorophyll, though they vary in their shapes and sizes. Leaves are the part of the plant that ordinarily performs photosynthesis (the process that converts sunlight and carbon dioxide into energy). As used herein, "needle" generally refers to a narrow stiff leaf, such as those of conifers (e.g., pine trees). As used herein, "root" refers to the part of a plant, normally underground, that absorbs nutrients and anchors the plant into the ground. As used herein, "bulb" refers to a spheroidal body growing from a plant either above or below the ground (usually below), which is usually a bud, consisting of a cluster of partially developed leaves, and producing, as it grows, a stem above, and roots below, (e.g., the onion or tulip bulb). A true bulb is a complete package containing next year's plant (flower) already forming inside. The contents of the bulb are often enclosed in protective, fleshy scales, which are held together by a small basal plate. The scales are modified leaves that contain enough nutrients to sustain the plant through dormancy and early growth. They may be loose and open like those of a lily, or tightly closed like those of a hyacinth. In many bulbs, a paper-thin tunic protects the scales (lilies don't have a tunic). Roots will grow from the bulb's basal plate. As used herein, "beny" refers to any small fruit that is pulpy or succulent throughout, having seeds loosely imbedded in the pulp, such as the cunant, grape, or bluebeny. Beny can be further defined as an indehiscent fruit derived from a single ovary and having the whole wall fleshy, such as the grape or tomato. Furthermore, benies come in various stmctures including simple, such grape; bluebeny, cranberry, or aggregate, such as blackbeny; raspbeny, strawbeny mulbeny. As used herein, "rhizome" refers to a horizontal, usually underground stem that often sends out roots and shoots from its nodes (also called rootstalk or rootstock). As used herein, "rootstock" refers to a robust plant that provides the root system in grafting, also known as a stock. Scions and buds are grafted and budded to a rootstock or stock. Rootstock also refers to the elongated and often thick rhizomes of certain perennial herbaceous plants such as the Iris, Aspidistra and Solomon's Seal. .
As used herein, "stem" refers to the main (usually aerial) axis (sometimes refened to as the trunk or stalk) of a tree, shrub, or plant. "Stem" also refers to the part of the plant that supports the leaves, flowers or fruits of a plant, such as the peduncle of a fruit or the pedicel of a flower. As used herein, "seed" refers to a ripened ovule, consisting of an embryo with one or more integuments, or coverings, such as an apple seed, a cunant seed, dill seed, or kola nut seed. By germination, most seeds produces a new plant. "Seed" also refers to any small seedlike fruit, though it may consist of a pericarp, or even a calyx, as well as the seed proper, such as a parsnip seed or thistle seed. The seed proper has an outer and an inner coat, and within these the kernel or nucleus. The kernel is either the embryo alone, or the embryo enclosed in the albumen, which is the material for the nourishment of the developing embryo. The scar on a seed, left where the stem parted from it, is called the hilum, and the closed orifice of the ovule, the micropyle.
Plant The plant can be a bryophyte or vascular plant. More specifically, the plant can be grass, flower or a tree and the plant tissue can be any part of the grass, flower or tree. Specific plants, flowers, and trees include, e.g., Moss (e.g., Club Moss), Horsetail, Fern, Conifer, Cycad, Ginkgo biloba (Ginkgo), Taxus yunnanesis (yew tree), Echinacea spp., Valeriana officinalis, Allhmi sativum (garlic), Panax ginseng, aloe vera, Vaccinium macrocarpon, Eleutherococcus senticosus, Piper methysticum, dill, kola nut, and cinchona. Another specific plant is the birch tree, wherein the suitable plant tissue can be the bark of the birch tree. As used herein, "birch" or "birch tree" refers to any of the several deciduous tress of the genus Betula. The birches comprise the family Betulaceae in the order Fagales. Birch trees include, for example, white birch, B. alba; sweet, black or cheny birch, B. lenta; monarch birch, B. maximowicziana; dwarf or arctic birch; B. nana; Japanese white birch, B. platphyla japonica; smooth-bark birch, B. pubescens; yellow birch, B. alleghaniensis; paper, white or canoe birch, B. papyrifera; gray birch, B. populifolia; river birch, B. nigra; and the European birches, B. pubescens; B. alba and B. pendula. Specifically, birch can be B. alba, B. lenta, B.
maximowicziana, B. nana, B. platyphylajaponica, B. pubescens, B. alleghaniensis, B. papyrifera, B. populifolia, B. nigra or B. pendula. A specific birch for use in the processes of the present invention is B. papyrifera. As used herein, " Taxus" or "yew" refers to plants belonging to Taxaceae Gymnopenmae. There are 11 species and five sub-species of Taxus in the world, mainly found in East Asia, North America, and Europe; , "Echinacea spp." Refers to a perennial native to North American which resembles a black-eyed Susan and is called Dchinacea, purple coneflower or snake root; "Valeriana offlcinalis" or "valerian" refers to the plant Valeriana ofβcinalis of the valerianaceae family, which is also known as valerian, phu, allheal, great wild valerian, amantilla, setwall, setewale, capon's tail; "Allium sativum" refers to garlic; "Panax ginseng" refers to ginseng, commonly called Korean ginseng, Chinese ginseng or American ginseng. Asian ginseng is a member of the
Araliaceae family, which also includes the closely related American ginseng, Panax quinquefolius, and less similar Siberian ginseng; "Eleutherococcus senticosus," refers to "eleuthero" (which contains eleutheroside A, eleutheroside B (syringin), eleutheroside C, eleutheroside D, eleutheroside E (syringaresinol di-O-β-D-glucoside, liriodendrin), and eleutheroside G, among other constituents); "Aloe" refers to any of the over 500 different species of Aloe. Aloe Vera is a member of the Lily family and is very-cactus like in its characteristics. This unique plant also belongs to a larger plant family called "Xeroids". Of the 500+ species of Aloe, Aloe barbaclensis miller (Aloe Vera species) is prefened; "Vaccinium macrocarpon" refers to cranbeny; "Piper methysticum," a member of the pepper family, refers to a plant native to the South Sea Islands of Micronesia, Melanesia and Polynesia; "Kola vera," of the family N.O. Sterculiaceae, also known as "Kola nut" refers to the tree that grows about 40 feet high and has yellow flowers spotted with purple; and
"Cinchona," belongs to the family N.O. Rubiaceae and refers to Peruvian bark (Cinchona succimbra) which is an evergreen tree that grows 15 to 45 feet in height.
Plant Components (non-acidic compounds and acidic compounds) The specific non-acidic compounds and acidic compounds that can be isolated from the plant tissue will depend, in part, upon the specific plant tissue that is being extracted. For example, the bark of Taxus yunnanesis can be extracted employing the methods described herein to provide taxol (paclitaxel) as the non-acidic compound and tannin, fatty acids, and phenols as the acidic compounds; the needles of the Yew tree can be extracted employing the methods described herein to provide taxol (paclitaxel) as the non-acidic compound, and tannin, fatty acids, and phenols as the acidic compounds; the root of the Echinacea spp. Can be extracted employing the methods described herein to provide Echinacea extract as the non-acidic compound and tannin, caffeic acid, and cichoric acid as the acidic compounds; the root of the Valeriana officinalis can be extracted employing the methods described herein to provide Valerian root extract as the non-acidic compound and valerenic acid, isovaleric acid, and tannins as the acidic compounds; the roots, bark, leaves, or any combination thereof of the Ginkgo biloba can be extracted employing the methods described herein to provide Ginkgolide A, Ginkgolide B, Ginkgolide C, and bilobalide as the non-acidic compounds and tannins, flavonoids (e.g., quercetin, kaempferol, catechin), lignins, shikimic, and succinic acids as the acidic compounds; the bulb of the Allium sativum can be extracted employing the methods described herein to provide garlic extract as the non-acidic compound and fatty acids and amino acids as the acidic compounds; the root of the Panax ginseng can be extracted employing the methods described herein to provide Ginseng extract as the acidic compound and tannin, fatty acids, nicotinic acid and pantothenic acid as the acidic compound;
the leaves of the Aloe Vera can be extracted employing the methods described herein to provide aloe gel and barbaloin as the non-acidic compounds and fatty acids, anthraquinones, acidic gelactan, and amino acids as the acidic compounds; the berries of the Vaccinium macrocarpon can be extracted employing the methods described herein to provide cranbeny extract as the non-acidic compounds and benzoic acid, quinic acid, malic acid, citric acid, and hippuric acid as the acidic compounds; the roots, rhizomes, stems, leaves, or combination thereof of the Eleutherococcus senticosus can be extracted employing the methods described herein to provide Eleutherosides A-G as the non acidic compounds and tannin, fatty acids, and caffeic acid as the acidic compounds; the rootstock of the Piper methysticum can be extracted employing the methods described herein to provide Kava extract as the non-acidic compounds and tannin, fatty acids, and amino acids as the acidic compounds; the seeds of the Dill can be extracted employing the methods described herein to provide seed oil as the non-acidic compound and phenolic acids (caffeic acid, feralic acid, and chlorogenic acid) as the acidic compounds; the seeds of the Kola nut can be extracted employing the methods described herein to provide kola extract as the non-acidic compounds and tannin and catechins as the acidic compounds; and the bark of the cinchona (yellow or red) can be extracted employing the methods described herein to provide quinolone alkaloids as the non-acidic compounds and norsoloric acid, tannins, and quinic acid as the acidic compounds.
Table 1 Non-acidic compounds and acidic compounds that can be isolated from specific plant tissue.
"Paclitaxel" refers to [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),- l l,αl2α,12aα,12bα]]-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,l l,12,12a,12b- dodecahydro-4,1 l,-dihydroxy-4a,8, 13, 13-tetramethyl-5-oxo-7,l 1-methano-lH- cyclodeca[3,4]benz[l,2-b]oxet-9-yl ester. "Echinacea extract" is believed to include essential oil, polysaccharides, such as inulin, polyacetylenes, betain, glycoside, sesquiterpenes and caryophylene. Echinacea extract is also believed to contain copper, iron, tannins, protein, fatty acids, fat-soluble alkylamides, caffeic acid glycoside (echinacoside), and vitamins A, C, and E. "Valeriana officinalis extract" is a very effective sedative and is used most often to help insomnia, especially due to stress. It has an advantage over prescription sedatives in that it is not habit forming. Valerian has many actions besides its well-known sedative effects. It strengthens the heart and in some cases lower blood pressure. It promotes wound healing and has some antibiotic activity and may be used externally to relieve muscle cramps. It has some expectorant activity and may help a tickly cough. It may actually balance the nervous system helping to calm agitated states and stimulate cases of extreme
fatigue. There are several species of valerian, which vary in potency and can be used similarly, although V. officinalis is the prefened plant. Other constituents are a volatile oil, which includes isovalerianic acid and bomeol; choline; flavonoids; sterols and several alkaloids, including actinidine, valerianine, valerine, and chatinine. Valepotriates are not water-soluble, but valeric acid is and may be the constituent most likely to produce valerian's sedative effect, especially when used as it was traditionally in water extracts (teas) or water/alcohol extracts (tinctures). The genus Ziziphus (ber, jujube) belongs to the buckthorn familiy (Rhamnaceae). It is a genus of about 100 species of deciduous or evergreen trees and shrubs distributed in the tropical and subtropical regions of the world. Some species, like Z. mauritiana and Z. jujuba, occur on nearly every continent, whereas other species, like Z. nummularia, Z. spina-christi and Z. mucronata, are restricted in their distribution to distinct areas. Ziziphus species can grow either as trees and shrubs (Z. mauritiana, Z. rotundifolia, Z. jujuba, Z. mucronata) or exclusively as small shrubs or bushes (Z. nummularia, Z. lotus, Z. spina-christi, Z. obtusifolia). This is a tree that may be used for manufacturing betulinic acid. Many studies have provided clinical evidence that ginkgo prevents many problems throughout the entire body. Ginkgo is gaining recognition as a brain tonic that enhances memory because of its positive effects on the vascular system, especially in the cerebellum. It is also used as a treatment for vertigo, tinnitus (ringing in the ears) and a variety of neurological disorders and circulation problems. Ginkgo may help to counteract the effects of aging, including mental fatigue and lack of energy. Ginkgo has two groups of active substances, flavonoids (a three-ringed molecule with hydroxyl (OH) groups attached) and terpene lactones, including ginkgolides A, B, and C, bilobalide (a sesquiterpene), quercetin (a flavonoid), and kaempferol (a flavonoid). The constituents of gingko include terpenoids (bilobalide), diterpenoids (ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J, ginkgolide M), flavonoids: flavones (luteolin, tricetin, 2-hydroxyluteolin), biflavones (amentoflavone, ginkgetin, isoginkgetin, sciadoptysin, 5-methoxybilobetin, bilobetin), flavonols
(caempherol, quercetin, isorhammetin), flavone glycosides, flavone acyl glycosides, catechins, and steroids (sitosterol, sitosterol glucoside). The
ginkgolides have been shown to control allergic inflammation, anaphylactic shock and asthma. Ginkgo extract is generally derived from dried ginkgo leaves, but also may be derived from gingko root or bark. "Garlic" contains compounds that are antibacterial, antifungal and reduce blood clotting. In order for the active ingredient that gives garlic its characteristic odor and its therapeutic effects to be released, the garlic clove (or bulb) must be cut or crashed. This releases an enzyme that causes the formation of allicin, the component responsible for garlic's odor and medicinal activity. Active constituents present in garlic include the sulphur compound allicin, produced by crashing or chewing fresh garlic, which in turn produces other sulphur compounds: ajoene, allyl sulfides, and vinyldithiins. "Ginseng" is believed to increase energy, counter the effects of stress, and enhance intellectual and physical perfomiance. Thirteen ginsenosides have been identified in ginseng, including ginsenosides Rgl and Rbl. Other constituents include the panaxans, which are believed to help lower blood sugar, and the polysaccharides (complex sugar molecules), which are believed to support immune function. Also, long-term intake may be linked to a reduced risk of cancer. Applied to wounds, "aloe" is a mild anesthetic, relieving itching, swelling, and pain: it also is antibacterial and antifungal, increases blood flow to wounded areas, and stimulates fibroblasts, the skin cells responsible for wound healing. "Cranbeny" has astringent applications for the urinary tract and is a traditional remedy for bladder infections and kidney-related disorders. Two components of cranbeny juice have been shown to inhibit the adherence of E. coli to uroepithelial cells. The first is fructose. The second is proanthocyanidin, the chemical structure of which has been elucidated. Fructose inhibits the adherence of type-1 fimbriated E. coli and proanthocyanidin inhibits the adherence of P-fimbriated E. coli to uroepithelial cells. Cranbeny is also a natural diuretic and urinary antiseptic agent. Although "kava" has undergone much research as to its active ingredients, there is still no definite conclusion. It consists of an oleoresin from which kavalactones originate, starch, sugars, proteins, vitamins Bl, B2, B3, B6,
folic acid and E, potassium, manganese, biotin, choline, inositol, fat, glycynhizin, lecithin, pantothenic acid, para-aminobenzoic acid, pentacyclic terpenes, phosphorous, and a yellow dye. Kavalactones are considered the most active constituents in the plant. The main use for kava today is in the treatment of anxiety. It is also an excellent muscle relaxant and has diuretic and urinary antiseptic properties, so it may be useful in urinary cystitis and prostatitis. Kava also shows pain-relieving properties. "Kola vera " or "Cola vera " seeds are said to contain a glucoside, Kolanin (this substance may be a mixture of Kola red and caffeine). The seeds also contain starch, fatty matter, sugar, and a fat decomposing enzyme acting on various oils. "Dill seed" is an herbal medicine that is used to reduce gas, upset stomach, and colic pains. It is also used to promote the flow of milk in breastfeeding mothers, and to help control bad breath and hiccups. Other names for Dill Seed include: Anethum Graveolens, Dill, and Dillweed. As used herein, "tannin" refers to tannic acid or gallotannic acid. Tannin varies somewhat in composition, depending on the source, having the approximate empirical formula C76H520 6. Tannic acid is a colorless to pale yellow solid; it is believed to be a glucoside in which each of the five hydroxyl groups of the glucose molecule is esterified with a molecule of digallic acid. Tannin is used in tanning animal skins to make leather; it transforms certain proteins of animal tissue into compounds that resist decomposition. It is also used in manufacturing inks, as a mordant in dyeing, and in medicine as an astringent and for treatment of burns. As used herein, "fatty acids" refers to a long-chain of carboxylic acids that may either be saturated (without double bond) or non-saturated (with double bond). It refers to any acid derived from fats by hydrolysis (e.g., oleic acid, palmitic acid, or stearic acid); any long-chain monobasic organic acid. As used herein, "phenols" refers to compounds that include a C6H5OH backbone. They are aromatic alcohols that are optionally substituted by one or more substituents. Phenols exhibits weak acidic properties and are sometimes called carbolic acids, especially when in water solution.
As used herein, "caffeic acid" refers to 3-(3,4-Dihydroxyphenyl)-2- propenoic acid. As used herein, "valeric acid" refers to pentanoic acid; valerianic acid; and propylacetic acid. As used herein, "isovaleric acid" refers to 3-Methylbutanedioic acid and isovalerianic. As used herein, "flavonoid" refers to polyphenols that have a carbon skeleton. They have an acidic nature due to the phenol groups. As used herein, quercetin refers to 2-(3,4-Dihydroxyphenol)-3,5,7- trihydroxy-4H-l -benzopyran-4-one. As used herein, "kaempferol" refers to 3,5,7-Trihydroxy-2-(4- hydroxyphenyl)-4H- 1 -benzopyran-4-one. As used herein, "catechin" refers to (2R-trans)-2-(3,4-dihydroxyphenyl)- 3,-4-dihydro-2H-l-benzopyran-3,5,7-triol. As used herein, "lignin" refers to a highly polymerized and complex chemical compound especially common in woody plants. The cellulose walls of the wood become impregnated with lignin, a process called lignification, which i greatly increases the strength and hardness of the cell and gives the necessary rigidity to the tree. It is believed to be essential to woody plants for them to stand erect. As used herein, "amino acids" refers to any one of a class of simple organic compounds containing carbon, hydrogen, oxygen, nitrogen, and in certain cases sulfur. These compounds are the building blocks of proteins. They are characterized by the presence of a carboxyl group (COOH) and an amino group (NH2). The 20 amino acids commonly found in animals are alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. More than 100 less common amino acids also occur in biological systems, particularly in plants. Every amino acid except glycine can occur as either of two optically active stereoisomers, D or L; the more common isomer in nature is the L-fonn. When the carboxyl carbon atom of one amino acid covalently binds to the amino nitrogen atom of another amino acid with the release of a water molecule, a peptide bond is formed.
As used herein, "shikimic acid" refers to [3R-(3α,4α,5β]-3,4,5- Trihydrooxy- 1 -cyclohexene- 1 -carboxylic acid. As used herein, "succinic acid" refers to butanedioic acid (HOOCCH2CH2COOH). As used herein, "nicotinic acid" refers to 3-Pyridinecarboxylic acid. As used herein, "pantothenic acid" refers to "(R)-N-(2,4-Dihydroxy-3,3- dimethyl- 1 -oxobutyl)- β-alanine. As used herein, "anthraquinone" refers to 9,10-anthracenedione. As used herein, "acidic galactan" refers to a poly sugar with attached carboxylic groups. As used herein, "benzoic acid" refers to benzoic acid, C6H5CO2H. It is the simplest aromatic carboxylic acid. In addition to being synthesized from a variety of organic compounds (e.g., benzyl alcohol, benzaldehyde, toluene, and phthalic acid), it may be obtained from resins, notably gum benzoin. It is used largely for making its salts and esters, most notably sodium benzoate, which is widely used as a preservative in foods and beverages and as a mild antiseptic in mouthwashes and toothpastes. As used herein, "quinic acid" refers to [lR-(lα,3α,4α,5β]-l,3,4,5- Tetrahydroxycyclohexanecarboxylic acid. As used herein, "malic acid" refers to hydroxybutanedioic acid. As used herein, "citric acid" refers to citric acid or 2-hydroxy- 1,2,3 - propanetricarboxylic acid, H02CCH2C(OH)(CO2H)CH2CO2H, an organic carboxylic acid containing three carboxyl groups. It is responsible for the tart taste of various fraits in which it occurs, e.g., lemons, limes, oranges, pineapples, and goosebenies. As used herein, "hippuric acid" refers to N-Benzoylglycine. As used herein, "feralic acid" refers to 3-(4-Hydroxy-3-methoxyphenyl)- 2-propenoic acid. As used herein, "chlorogenic acid" refers to [lS-(lα,3β,4α,5 ]-3-[[3- (3,4-Dihydroxyphenyl)-l -oxo-2-propenyl]oxy]- 1 ,4,5,trihydroxycyclohexanecarboxylic acid. As used herein, "cinnamic acid" refers to 3-phenyl-2-propenoic acid.
Betulinic acid can also be obtained from Tanzanian Tree Uapaca nitida Mull-Arg (Euphorbiacea), leaves and bark oϊBacopa monniera( West Bengal), all species of Dilleniacea (Acrotrema arnothianum Wight, Dillenia andamanica Parkinson, D. aurea Smith, D. bracteata Wight, D. indica Linn, D. pentagina Roxb, D. retusa Thunb, D. scabtalla (D. Don) Roxb, ex Wall, Tetracera (Houtt. exChrism.& Panz., Men.), Tetracera akara (Burm.f.) Men., T. indica (Houtt. exChrism.& Panz., Men.), T. sarmentosa(L.) Vahl. Subsp. Andamanica (Hoogl.) HoogL, and T. scandens (L.) Men. As used herein, "separating" refers to the process of removing solids from a mixture. The process can employ any technique lαiown to those of skill in the art, e.g., decanting the mixture, filtering the solids from the mixture, or a combination thereof. As used herein, "filtering" refers to the process of removing solids from a mixture by passing the liquid through a filter, thereby suspending the solids on the filter. As used herein, "decanting" refers to the process of pouring off a liquid without disturbing the sediment, or the process of pouring off a liquid with a minimal disturbance of the sediment. As used herein, "aqueous base" refers to a solution of water, and a substance that produces OH ions in the aqueous solution. Specifically, the aqueous base can include water and at least one of a lithium ion (Li+), a sodium ion (Na+), a potassium ion (K+), a calcium ion (Ca"+), and a barium ion (Ba+). More specifically, the aqueous base can include water and at least one of sodium hydroxide (NaOH) and potassium hydroxide (KOH). As used herein, "alkaline metal" refers to metals of Group IA of the
Periodic Table of Elements, e.g., sodium (Na) and potassium (K). As used herein, "alkaline earth metal" refers to metals of Group IIA of the Periodic Table of Elements, e.g., magnesium (Mg) and calcium (Ca). The present invention employs a solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C. In one embodiment, the solvent is water-immiscible. In another embodiment, the solvent is capable of forming an azeotropic mixture with water. In another embodiment, the solvent has a boiling point of at least
100°C. In another embodiment, the solvent is water-immiscible and is capable of forming an azeotropic mixture with water. In another embodiment, the solvent is water-immiscible and has a boiling point of at least 100°C. In another embodiment, the solvent is capable of forming an azeotropic mixture with water and has a boiling point of at least 100°C. In one embodiment, the solvent having a boiling point of at least 100°C can have a boiling point of at least about 120°C, at least about 140°C, or at least about 160°C. It is appreciated that those of skill in the art understand that the solvent should not chemically react with any of the starting materials or reagents present in the reaction mixture, to any significant degree, under the reaction conditions employed. For example, the solvent should not react with the alkaline present at the elevated temperatures typically employed during the heating step. As used herein, "water-immiscible solvent" refers to a solvent that is not miscible (i.e., not capable of mixing in all proportions) with water. Suitable specific water-immiscible solvents include, e.g., aromatic hydrocarbons such as xylenes, oxylene, nt-xylene, τ xylene, toluene, benzene, and combinations thereof; chlorinated solvents such as chloroform and methylene chloride; as well as other organic solvents such as ethyl-tert-butyl ether and ethyl acetate. As used herein, "water-miscible solvent" refers to a solvent that is miscible (i.e., is capable of mixing in all proportions) with water. Suitable specific water-miscible solvents include, e.g., methanol, ethanol, z'so-propanol, tert-butanol, ethylene glycol, acetone, 1-propanol and propylene glycol. As used herein, "distill" or "distillation" refers to the process of extracting the volatile components of a mixture by the condensation and collection of the vapors that are produced as the mixture is heated. The process includes the evaporation and subsequent collection of a liquid by condensation. As used herein, "concentrating" or "condensing" refers to the process whereby the volume is reduced, by the removal of liquid. As used herein, "mother liquor" refers to the liquid obtained after solids are removed from a mixture or a solution of solids in a liquid. As such, the mother liquor will not include an appreciable amount of these solids.
As used herein, "birch" refers to any of the several deciduous trees of the genus Betula. The birches comprise the family Betulaceae in the order Fagales. Birch trees include, for example, white birch, B. alba; sweet, black or cheny birch, B. lenta; monarch birch, B. Maximowicziana; dwarf or arctic birch, B. Nona; Japanese white birch, B. Platyphyla Japonica; smooth-bark birch, B. Pubescens; yellow birch, B. alleghaniensis; paper, white or canoe birch, B. papyrifera; grey birch, B. populifolia; river birch, B. nigra; and the European birches, B. pubescens; B. Alba and B. pendula. Specifically, the birch can be B. alba, B. lenta, B. Maximowicziana, B. Nana, B. Platyphyla Japonica, B. Pubescens, B. alleghaniensis, B. papyrifera, B. populifolia, B. nigra, B. pubescens, B. Alba or B. pendula. A specific birch for use in the processes of the present invention is B. papyrifera. As used herein, "birch bark" refers to inner birch bark and outer birch bark. Inner birch bark is more dense and granular than outer birch bark, while outer birch bark is more flexible and fibrous than inner birch bark. Outer birch bark is light in color, thin (1-5 mm), tough, and of low water-content relative to inner birch bark. The inner bark is darker in color, thicker (3-10 mm) and non- fibrous relative to the outer bark. The inner bark is the portion of the tree wherein significant water transport occurs (i.e., an area of high water content). Due to the differences in the physical properties of inner birch bark and outer birch bark, fragmentation produces outer birch bark shreds and inner birch bark chunks. Outer birch bark shreds can be separated from the inner birch bark chunks using any suitable means. The separation can conveniently be accomplished by screening the mixture through a mesh having openings intermediate in size between the smaller inner bark chunks and the larger outer bark shreds. The smaller inner bark chunks fall through the screen and are separated from the outer bark. The "mesh" can be a unit comprising one or more open spaces in a cord, thread, or wire network in which the cords, threads or wires sunound the spaces. Any mesh suitable to separate inner birch bark from outer birch bark can be employed. Typically, the mesh is a wire mesh containing openings of about 54 of an inch by 54 of an inch, or smaller. For example, mesh can conveniently
contain openings of about 1/4 of an inch by about 1/4 of an inch. Specifically, the size of the mesh can be about 20 mm by about 20 mm, or about 10 mm by about 10 mm, or about 6 mm by about 6 mm. More specifically, the size of the mesh can be about 3 mm by about 3 mm. Alternatively, the inner birch bark chunks and outer birch bark shreds may be separated with the use of an air classifier. As used herein, an "air classifier" is a device which operates on the principle of the differing properties of the two components (e.g., imier and outer birch bark) in an air stream to effect a physical separation. Typically, the less dense outer bark travels a greater distance in the air stream than the more dense imier bark. The imier bark, along with other materials, falls rapidly from the stream of air. As a result, the inner birch bark and the outer birch bark can be separated. After separating outer birch bark from inner birch bark, outer birch bark of about 10 wt.%) to about 45 wt.% based on initial birch bark content is typically obtained and inner birch bark of about 55 wt.% to about 85 wt.% is typically obtained. For use in the processes of the present invention, birch bark shreds less than about 10 mm in diameter can conveniently be used. More specifically, outer birch bark shreds less than about 6 mm in diameter, less than about 4 mm in diameter, or less than about 2 mm in diameter, can be used. Alternatively, birch bark pellets of about 5.0 mm in length by about 4 mm in diameter, or about 2.5 mm in length by about 2 mm in diameter can conveniently be used, hi addition, bark pellets of about 0.25 kg/liter to about 1.0 kg/liter, or about 0.5 kg/liter to about 0.7 kg/liter can conveniently be used. As used herein, "aromatic hydrocarbon" refers to a compound having at least one phenyl or naphthyl ring, wherein the compound contains carbon and hydrogen atoms. The aromatic hydrocarbon can optionally be substituted, e.g., with one or more groups selected from the group of alkyl (e.g., methyl), hydroxyl, halo, alkoxy, cyano, carboxyl, sulfonyl, and amino. Suitable specific aromatic hydrocarbons include, e.g., xylenes, o-xylene, -xylene, p-xylene, toluene, benzene, and combinations thereof.
As used herein, "reflux" refers to the process of boiling a liquid in a vessel attached to a condenser so that the vapors continuously condense for reboiling. As used herein, "washing" refers to the process of purifying a solid mass (e.g., crystals) by passing a liquid over and/or through the solid mass, as to remove soluble matter. The process includes passing a solvent, such as distilled water, over and/or through a precipitate obtained from filtering, decanting, or a combination thereof. For example, in one embodiment of the invention, washing includes contacting solids with water, vigorously stirring (e.g., for two hours), and filtering. The solvent can be water, can be an aqueous solvent system, or can be an organic solvent system. Additionally, the washing can be ca ied out with the solvent having any suitable temperature. For example, the washing can be carried out with the solvent having a temperature between about 0°C and about 100°C. As used herein, a "binder" refers to a substance that can effectively bind
(i.e., chemically attach itself, physically attach itself and/or chemically react) with selective compound(s) present in a mixture. It is believed that substances such as aluminum alcoholates bind strongly and ineversibly to triterpenoid or triterpene acids and tannins, therefore providing complete discoloration of cmde birch bark extract. Suitable binders useful in the present invention include, e.g., metal hydrides (e.g., lithium hydride (LiH), sodium hydride (NaH), potassium hydride (KH), calcium hydride (CaH ), and lithium aluminum hydride (LiAlH ); metal alcoholates (e.g., sodium methoxide (NaOMe), sodium ethoxide (NaOEt), potassium methoxide (KOMe), potassium ethoxide (KOEt), aluminum iso- propoxide [Al(i-OPr)3], aluminum tert-butoxide [Al(t-OBu)3], and aluminum methoxide [Al(OMe)3]), ortho-esters (e.g., ethylorthocarbonate), dialkoxysulfates (e.g., dimethylsulfate and diethylsulfate), alumina and silica. As used herein, "metal hydride" refers to a binary compound of hydrogen and a metal. Suitable metal hydrides include e.g., lithium hydride (LiH), sodium hydride (NaH), potassium hydride (KH), calcium hydride (CaH2), and lithium aluminum hydride (LiAlH ). As used herein, "metal alcoholate" or "alcoholate" refers to an organic alcohol wherein the hydroxy hydrogen has been replaced with a metal, e.g.,
(CH CH 0)3A1. Aluminum alcoholates are suitable reagents for triterpene purification because it is believed that aluminum alcoholates bind strongly and ineversibly to acids and tannins, therefore providing complete discoloration of the total extract. Suitable specific metal alcoholates include, e.g., sodium methoxide (NaOMe), sodium ethoxide (NaOEt), potassium methoxide (KOMe), potassium ethoxide (KOEt), aluminum wø-propoxide [Al(i-OPr)3], aluminum tert-butoxide [Al(t-OBu)3], and aluminum methoxide [Al(OMe) ]. As used herein, "hydro lyze" or "hydrolysis" refers to the process of converting a carboxylic ester to the conesponding carboxylic acid, with the addition of water. The reaction (i.e., hydrolysis) can conveniently be canied out employing any suitable reagent(s) and reaction condition(s). For example, the reaction can be canied out in a suitable solvent and at a suitable temperature and pressure, under basic conditions, neutral conditions, or acidic conditions. Suitable reagents and reaction conditions are disclosed, e.g., in Advanced Organic Chemistry, Part B: Reactions and Synthesis, Carey and Sundberg,
Plenum Press; Comprehensive Organic Transformations, Larock, Wiley & Sons; and Advanced Organic Chemistry, Reactions Mechanisms, and Stmcture, March, McGraw Hill. For example, the hydrolysis can be carried out at a pH of greater than about 7.0 (e.g., a pH of about 7-8, 8-9, 9-10, 10-11, or 11-12). When the hydrolysis is carried out at a pH of greater than 7.0, one or more suitable bases will typically be employed. Suitable bases include metal hydroxides and metal alkoxides. Suitable metal hydroxides include sodium hydroxide, potassium hydroxide, lithium hydroxide, calcium hydroxide and barium hydroxide. Suitable metal alkoxides include lithium methoxide, lithium ethoxide, lithium isopropoxide, lithium tert-butoxide, sodium methoxide, sodium ethoxide, sodium isopropoxide, sodium tert-butoxide, potassium methoxide, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide, magnesium methoxide, magnesium ethoxide, barium methoxide, barium ethoxide, calcium methoxide and calcium ethoxide. A specific base suitable for the processes of the present invention (i.e., hydrolysis of birch bark) is sodium hydroxide. Alternatively, the hydrolysis can be carried out at a pH of less than about
7.0 (e.g., a pH of about 1-2, 2-3, 3-4, 4-5, 5-6, or 6-7). When the hydrolysis is
canied out at a pH of less than about 7.0, one or more suitable acids will typically be employed. Suitable acids include, for example, hydrochloric acid, phosphoric acid, formic acid, hydi'obromic acid, sulfuric acid, nitric acid, acetic acid, and combinations thereof. A specific acid suitable for the processes of the present invention (i.e., hydrolysis of birch bark) is sulfuric acid. Alternatively, the hydrolysis can be earned out at a pH of about 6.5 to about 7.5 (i.e., neutral conditions). When the hydrolysis is canied out at about 6.5 to about 7.5 (i.e., neutral conditions), water at standard pressure or at an elevated pressure can be employed. As used herein, "natural ester" refers to an organic compound (e.g., triterpenes or triterpenoids) having at least one carboxylic ester group. As used herein, "azeotropic distillation" refers to the process of boiling off or distilling any liquid mixture having constant minimum and maximum boiling points and distilling off without decomposition and in a fixed ratio, as with benzene and water, or as with toluene and water. In a specific embodiment, the azeotropic distillation can include the co -distillation of water and at least one of xylenes, oxylene, -xylene, p-xy\ene, toluene, and benzene. Such a distillation can be canied out at a temperature and a period of time, effective to distill or boil more than about 90% of the water, more than about 95% of the water, more than about 98% of the water, or up to about 100 wt.% of the water. With the distillation or boiling off of the water, it is appreciated that those of skill in the at recognize that a discrete amount of the organic solvent (e.g., xylenes, o-xylene, m-xylene, p-xylene, toluene, and/or benzene) will also distill or boil off with the water. As used herein, "azeotropic mixture" refers to a mixture which would undergo azeotropic distillation. As used herein, "agitating" refers to the process of putting a mixture into motion with a turbulent force. Suitable methods of agitating include, e.g., stining, mixing, and shaking. As used herein, "precipitating" refers to the process of causing a solid substance (e.g., crystals) to be separated from a solution. The precipitating can include, e.g., crystallizing.
As used herein, "polar organic solvent" refers to an organic solvent having a measurable dipole. Specifically, it refers to an organic solvent having a dielectric constant of at least about 15, at least about 20, or between about 20 and about 30. As used herein, "non-polar organic solvent" refers to an organic solvent having no measurable dipole. Specifically, it refers to an organic solvent having a dielectric constant of less than about 15, less than about 10, or between about 6 and about 10. As used herein, "drying" refers to the removal of water and/or solvent, such that the water and/or solvent content is below about 5 wt.%, below about 2 wt.% or below about 1 wt.%. As used herein, "neutralizing" refers to the process of changing or bringing the pH to about 7 ± 1. As such, the neutralizing can include bringing the pH to about 6 to about 8. In a specific embodiment, the neutralizing can include bringing the pH to about 6.5 to about 7.5 (i.e., to a pH of about 7 ± 0.5). In yet another specific embodiment, the neutralizing can include bringing the pH to about 6.75 to about 7.25 (i.e., to a pH of about 7 ± 0.25). As used herein, "acidifying" refers to the process of lowering the pH to below 7.0. For example, in one specific embodiment, the acidifying includes lowering the pH to below about 6.0. In another specific embodiment, the acidifying includes lowering the pH to below about 5.0. h yet another specific embodiment, the acidifying includes lowering the pH to below about 4.0. As used herein, "purifying" refers to the process of ridding a solid substrate (e.g., crystals) of impurities. Suitable methods of purifying include, e.g., washing, recrystallizing and drying. In cases where compounds are sufficiently basic or acidic to form stable nontoxic acid or base salts, administration of the compounds as salts maybe appropriate. Examples of pharmaceutically acceptable salts are organic acid addition salts formed with acids, which form a physiological acceptable anion, for example, tosylate, methanesulfonate, acetate, citrate, malonate, tartarate, succinate, benzoate, ascorbate, α-ketoglutarate, and oglycerophosphate.
Suitable inorganic salts may also be formed, including hydrochloride, sulfate, nitrate, bicarbonate, and carbonate salts.
Pharmaceutically acceptable salts may be obtained using standard procedures well known in the art, for example by reacting a sufficiently basic compound such as an amine with a suitable acid affording a physiologically acceptable anion. Alkali metal (for example, sodium, potassium or lithium) or alkaline earth metal (for example calcium) salts of carboxylic acids can also be made. The compositions that include a compound obtained by the processes described herein, can be fonnulated as pharmaceutical compositions and/or cosmetic compositions, and administered to a mammalian host, such as a human patient in a variety of forms adapted to the chosen route of administration, i.e., orally or parenterally, by intravenous, intramuscular, topical or subcutaneous routes. Thus, the present compositions can be systemically administered, e.g., orally, in combination with a pham aceutically acceptable vehicle such as an inert diluent or an assimilable edible canier. They may be enclosed in hard or soft shell gelatin capsules, may be compressed into tablets, or may be incorporated directly with the food of the patient's diet. For oral therapeutic administration, the compositions may be combined with one or more excipients and used in the form of ingestible tablets, buccal tablets, troches, capsules, elixirs, suspensions, syrups, wafers, and the like. Such preparations should contain at least 0.1 % of the triterpene compound. The percentage of the compositions can, of course, be varied and may conveniently be between about 2 to about 60%) of the weight of a given unit dosage form. The amount of active compound (i.e., triterpene compound) in such therapeutically useful compositions is such that an effective dosage level will be obtained. The tablets, troches, pills, capsules, and the like may also contain the following: binders such as gum tragacanth, acacia, corn starch or gelatin; excipients such as dicalcium phosphate; a disintegrating agent such as com starch, potato starch, alginic acid and the like; a lubricant such as magnesium stearate; and a sweetening agent such as sucrose, fructose, lactose or aspartame or a flavoring agent such as peppermint, oil of wintergreen, or cheny flavoring may be added. When the unit dosage form is a capsule, it may contain, in addition to materials of the above type, a liquid canier, such as a vegetable oil or
a polyethylene glycol. Various other materials may be present as coatings or to otherwise modify the physical form of the solid unit dosage form. For instance, tablets, pills, or capsules may be coated with gelatin, wax, shellac or sugar and the like. A syrup or elixir may contain the active compound (i.e., triterpene), sucrose or fructose as a sweetening agent, methyl and propylparabens as preservatives, a dye and flavoring such as cheny or orange flavor. Of course, any material used in preparing any unit dosage form should be pharmaceutically acceptable and substantially non-toxic in the amounts employed. In addition, the active compound (i.e., triterpene) may be incorporated into sustained-release preparations and devices. The composition may also be administered intravenously or intraperitoneally by infusion or injection. Solutions of the triterpene can be prepared in water, optionally mixed with a nontoxic surfactant. Dispersions can also be prepared in glycerol, liquid polyethylene glycols, triacetin, and mixtures thereof and in oils. Under ordinary conditions of storage and use, these preparations contain a preservative to prevent the growth of microorganisms. The pharmaceutical dosage forms suitable for injection or infusion can include sterile aqueous solutions or dispersions or sterile powders comprising the active ingredient, which are adapted for the extemporaneous preparation of sterile injectable or infusible solutions or dispersions, optionally encapsulated in liposomes. In all cases, the ultimate dosage form, should be sterile, fluid and stable under the conditions of manufacture and storage. The liquid canier or vehicle can be a solvent or liquid dispersion medium comprising, for example, water, ethanol, a polyol (for example, glycerol, propylene glycol, liquid polyethylene glycols, and the like), vegetable oils, nontoxic glyceryl esters, and suitable mixtures thereof. The proper fluidity can be maintained, for example, by the formation of liposomes, by the maintenance of the required particle size in the case of dispersions or by the use of surfactants. The prevention of the action of microorganisms can be brought about by various antibacterial and antifungal agents, for example, parabens, chlorobutanol, phenol, sorbic acid, thimerosal, and the like. In many cases, it will be preferable to include isotonic agents, for example, sugars, buffers or sodium chloride. Prolonged absorption of
the injectable compositions can be brought about by the use in the compositions of agents delaying absorption, for example, aluminum monostearate and gelatin. Sterile injectable solutions are prepared by incorporating the triterpene in the required amount in the appropriate solvent with various of the other ingredients enumerated above, as required, followed by filter sterilization. In the case of sterile powders for the preparation of sterile injectable solutions, the prefened methods of preparation are vacuum drying and the freeze-drying techniques, which yield a powder of the triterpene, plus any additional desired ingredient present in the previously sterile-filtered solutions. For topical administration, the present compositions may be applied in pure form, i.e., when they are liquids. However, it will generally be desirable to administer them to the skin as compositions or formulations, in combination with a dermatologically acceptable canier, which may be a solid or a liquid. Useful solid carriers include finely divided solids such as talc, clay, microcrystalline cellulose, silica, alumina and the like. Useful liquid carriers include water, alcohols or glycols or water-alcohol/glycol blends, in which the triterpene can be dissolved or dispersed at effective levels, optionally with the aid of non-toxic surfactants. Adjuvants such as fragrances and additional antimicrobial agents can be added to optimize the properties for a given use. The resultant liquid compositions can be applied from absorbent pads, used to impregnate bandages and other dressings, or sprayed onto the affected area using pump-type or aerosol sprayers. Thickeners such as synthetic polymers, fatty acids, fatty acid salts and esters, fatty alcohols, modified celluloses or modified mineral materials can also be employed with liquid caniers to form spreadable pastes, gels, ointments, soaps, and the like, for application directly to the skin of the user. Examples of useful dermatological compositions which can be used to deliver the compositions of the triterpene, to the skin, are known to the art; for example, see Jacquet et al. (U.S. Pat. No. 4,608,392), Geria (U.S. Pat. No. 4,992,478), Smith et al. (U.S. Pat. No. 4,559,157) and Wortzman (U.S. Pat. No.
4,820,508). Useful dosages of the compositions of the triterpene can be determined by comparing their in vitro activity, and in vivo activity in animal models.
Methods for the extrapolation of effective dosages in mice, and other animals, to humans are known to the art; for example, see U.S. Pat. No. 4,938,949. Generally, the concentration of the compositions of the triterpene in a liquid composition, such as a lotion, will be from about 0.1-25 wt-%, preferably from about 0.5-10 wt-%. The concentration in a semi-solid or solid composition such as a gel or a powder will be about 0.1-5 wt-%, preferably about 0.5-2.5 wt- %. The amount of the triterpene, required for use in treatment will vary not only with the particular salt selected but also with the route of administration, the nature of the condition being treated and the age and condition of the patient and will be ultimately at the discretion of the attendant physician or clinician. In general, however, a suitable dose will be in the range of from about 0.5 to about 100 mg/kg, e.g., from about 10 to about 75 mg/kg of body weight per day, such as 3 to about 50 mg per kilogram body weight of the recipient per day, preferably in the range of 6 to 90 mg/kg/day, most preferably in the range of 15 to 60 mg/kg/day. The composition is conveniently administered in unit dosage form; for example, containing 5 to 1000 mg, conveniently 10 to 750 mg, most conveniently, 50 to 500 mg of triterpene per unit dosage form. Ideally, the composition should be administered to achieve peak plasma concentrations of the triterpene of from about 0.5 to about 75 μM, preferably, about 1 to 50 μM, most preferably, about 2 to about 30 μM. This maybe achieved, for example, by the intravenous injection of a 0.05 to 5% solution of the triterpene, optionally in saline, or orally administered as a bolus containing about 1-100 mg of the triterpene. Desirable blood levels may be maintained by continuous infusion to provide about 0.01-5.0 mg/kg/hr or by intermittent infusions containing about 0.4-15 mg/kg of the triterpene(s). The desired dose may conveniently be presented in a single dose or as divided doses administered at appropriate intervals, for example, as two, three, four or more sub-doses per day. The sub-dose itself may be further divided, e.g., into a number of discrete loosely spaced administrations; such as multiple inhalations from an insufflator or by application of a plurality of drops into the eye.
The ability of a composition of the invention to act, e.g., as an anti-fungal agent, anti-bacterial agent, and or anti- viral agent may be determined using pharmacological models which are well known to the art. The compositions of the invention maybe also be useful as pharmacological tools for the further investigation of the mechanism of their anti-fungal, anti-bacterial, and/or anti- viral action. The compositions of the invention can also be administered in combination with other therapeutic agents that are effective to treat, e.g., fungal infections, bacterial infections, and/or viral infections; or to inhibit or kill a fungus, bacterium, and/or virus. References in the specification to "one embodiment", "an embodiment", "an example embodiment", etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it is submitted that it is within the knowledge of one skilled in the art to affect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described. Refening to Figure 1, birch bark processing (1) utilizing distillation (6) is illustrated. The processing (1) provides for the isolation of betulinic acid (15), betulm (17), and/or lupeol (20). The processing includes extracting (3) outer birch bark (2) with an organic solvent to provide a birch bark extract (4). Suitable solvents, techniques and conditions for the extracting (3) are known to those of skill in the art. The extracting (3) will preferably employ suitable solvent(s) in which the desired compound(s) are relatively soluble. The extracting (3) can be canied out under conditions (e.g., temperature, pressure and period of time), effective to extract the desired compound(s) in a relatively high yield, while minimizing any decomposition of the desired compound(s). The extracting (3) effectively provides birch bark extract (4), which can subsequently be refluxed (21) with a metal hydroxide (5), distilled (6), and filtered/decanted (7), to provide the solids (8) and filtrate (9). The refluxing (21) of the birch bark extract (4) with the metal hydroxide (5) can be carried out
under conditions (e.g., temperature and period of time) and with reagents and solvents, effective to reflux (21) the reaction mixture, while minimizing any decomposition of the desired compound(s). Suitable metal hydroxides (5) are lαiown to those of skill in the art. The reaction mixture can then be distilled (6), to effectively remove water present in the reaction mixture. This distillation (6) will remove not only water, but also a discrete amount or organic solvent (e.g., xylenes, toluene and/or benzene) present in the reaction mixture. The distillation (6) will also not remove any appreciable amounts of metal hydroxides (5) along with the water. Additionally, no appreciable amounts of triterpenes or triterpenoids are removed with the water during the distillation (6). It is believed that the metal hydroxide reacts with acids (e.g., triterpenoid acids) while in solution, to provide the conesponding salts. These salts are relatively insoluble in the organic solvent employed. As such, the salts will precipitate from the solution after removal of the water during the distillation (6). The solids (8), which can be visible as a black tar, precipitates from solution, and can subsequently be separated (e.g., filtered or decanted (7)) from solution to provide the solid (8) and filtrate (9). As discussed below, the solid (8) contains betulinic acid (15), and can be purified accordingly. The filtrate (9) can be treated with binder (25) to provide a mixture. The mixture can be filtered (27) to provide a second filtrate. The second filtrate can be concentrated (29), and crystallized (30), to provide betulin (17) and a filtrate (16). This filtrate (16) can be concentrated (31), washed (33), crystallized (35), concentrated (36) and crystallized (37) to provide lupeol (20). The solid (8) described above can be washed with water (38), neutralized/acidified (10), filtered/decanted (11), and subsequently crystallized (12) to provide betulinic acid (15). Referring to Figure 2, plant matter processing (100) utilizing distillation (106) is illustrated. Plant matter (101) can be purified, to provide acidic components of plant mater extract (117) and non-acidic components of plant matter extract (120). Specifically, the plat matter (101) is extracted (102) to provide plant matter extract (103). The plant matter extract (103) can b e refluxed with a metal hydroxide (105), distilled (106), and filtered/decanted
(107), to provide solids (108) and filtrate (109). The solids (108) can be washed (130), neutralized/acidified (110), filtered/decanted (111), and crystallized (112), to provide acidic components of plant matter extract (117). The filtrate (109) can be contacted with binder (131), filtered (132), concentrated (113), and crystallized (114), to provide filtrate (115) and non-acidic component of plant matter extract (116). The filtrate (115) can be concentrated (140), washed (141), and crystallized (142) to provide non-acidic component of plant matter extract (120). The present invention will be described by the following examples. The examples are for illustration purposes and do not otherwise limit the invention. Examples Example 1 : Extraction of outer birch bark with xylenes Air-dry pellets of outer birch bark (200 g) were extracted with p-xylene (1 x 1 L) and then with p-xylene (3 x 300ml). Each time the extraction mixture was refluxed for 20 min and then filtered at 90°C. The solvent of the combined organic extracts was evaporated and the residue was dried at 80°C, in vacuum, to give 44 g (yield is 22 wt.%>) of dry birch bark extract. The p-xylene extract was used without further purification.
Example 2: Isolation of betulin The birch bark extract (44 g) obtained from the procedure in Example 1 was dissolved in xylenes (1.1 L) at 80°C. Sodium hydroxide (NaOH) (8.8g) was dissolved in 80°C water (17.4 ml). The two mixtures were combined, vigorously stined and refluxed for 1 hr. Water (17.4 ml) was removed from the reaction mixture by azeotropic distillation on a Dean-Stark trap, and the reaction mixture was filtered to remove the black tar that precipitated from solution. This black tar includes the crude sodium salts of triterpenoid acids (19.8 g), including betulinic acid, as shown in Example 4 below. To the mother liquor xylene solution obtained after filtration was added aluminum zso-propoxide [Al(Oi-Pr)3] (2.64 g, 12.9 mmol) and stined for lhr at 85°C. Alumina oxide (A1203) (4.4 g, acidic Brockman I) was added and the reaction mixture was stined for 4 hrs at 85°C, filtered and 800 ml of xylenes was evaporated. The resulting solution was
cooled to room temperature and left undisturbed for 10 hrs. The crystals were filtered, dried and 21 g (47.7 wt.%, based on the birch bark extract) of betulin (98% purity) was obtained. The concentration of betulinic acid in this betulin was less than 0.02 wt.% by GC/MS and HPLC analysis.
Example 3: Isolation of lupeol The mother liquid from Example 2 was evaporated to afford 11 g (25 %) of crade lupeol / betulin mixture. 20 ml of acetone was added to this mixture, stined at 60°C for one hour and cooled down 5-10°C for two hours. The yellowish precipitate (4.5 g) was filtered and crystallized from xylene. The mother liquid after xylene filtering was removed and the yellowish solid crystals of lupeol were crystalyzed from cyclohexane. The mother liquid after cycloxehane filtering was removed and the solids were washed with 5 ml of acetone, l.lg of white lupeol crystals (98%>+ purity) were obtained (yield is 2.5 wt.%), based on birch bark extract).
Example 4: Isolation of betulinic acid 19.8 g the sodium salts of triterpenoid acids obtained in Example 2 above was washed with water (4 x 100ml). The solid after filtration was acidified with a 5% solution of HCl in water (to ρH=5), filtered and dried to give 2.5 g of crade product. The crade product was then dissolved in 80 ml of wo-propanol (i-
PrOH), and 65 ml of wo-propanol (i-PrOH) was evaporated and filtered at 35°C.
The crystals were dried to provide 1.3 g (3 wt.%, based on birch bark extract) of betulinic acid (90 % purity). After a second crystallization from zso-propanol (i- PrOH) 0.9 g (2.0 wt.%, based on birch bark extract) of betulinic acid (99% purity) was obtained.
Example 5: Azeotropic distillation sing sodium hydroxide, water and xylenes A solution of NaOH (90g) in 180 ml of water was added to the vigorously stined solution of birch bark extract in xylenes* (13.5 L) at 90°C.
The stined solution was kept at 100°C for 1 hour. Azeotropic mixture of water and xylenes (total volume 4.0 L) was distilled (xylene recycling). The xylenes solution (9.5 L) was then filtered at 90-100°C into the heated up to 100°C reactor
and transfened to example 7. The black solid product was dried at 80°C for 5 hours in vacuum. This product (196g) was transfened to example 9 for betulinic acid separation and purification. * - The cheapest Xylene isomers mixture can be used for this purpose
(Aldrich 24,764-2; 18 L, $93.80).
Example 6: Azeotropic Distillation A solution of KOH (126g in 180 ml of water) was added to the ι vigorously stined solution of birch bark extract (456 g in 13.5 L of xylenes*) at 90°C. The stined solution was kept at 100°C for 1 hour. Azeotropic mixture of water and xylenes (total volume 4.0 L) was removed (xylene recycling). The solution was then filtered at 90-100°C. The black solid product was transfened from filter and dried at 80°C for 5 hours in vacuum. This product (221 g) was transfened to example 9 for betulinic acid separation and purification. * - The cheapest Xylene isomers mixture may be used for this purpose (Aldrich 24,764-2; 18 L, $93.80)
Example 7: Treatment with Dimethyl Sulfate and crystallization Recycled betulin (33 g) and 18.0 g of K2CO3 were added to the stined hot filtrate of treated with NaOH birch bark extract (350 g) in xylenes (9.5 L) (xylenes solution from example 5). This mixture was stined for 10 minutes at 100°C. Dimethyl sulfate (12 ml) was added and the resulting mixture was stined for 2 hrs. Then 180 ml of water was added and mixture was stined at 100°C for 0.5 hour. Xylenes (5.5 L) and water (170 ml) were removed by azeotropic distillation. The remain hot xylenes solution was filtered and left for crystallization at 10°C for 3 hours. The precipitate was filtered, washed with cold xylenes (2 times x 375 ml) and dried. The yield of 96%+ purity betulin was 261.4g (13%). The filtrate solution was used in Example 8 for Lupeol separation.
Example 8: Lupeol separation and betulin recycling
Xylenes were evaporated from and the filtrate solution (the filtrate solution from example 7). Acetone (0.5 L) was then added and the mixture was vigorously stined and refluxed for 1 hr. Then acetone solution was cooled down to room temperature and filtered. Operation with acetone was repeated three times. White solid material (83 g) after washing with acetone was dried and crystallized from 1.8 L of xylene. After filtration 37 g of solid white material (75% of betulin and 10% of lupeol, 15% others) was received and used in Example 7 as recycling betulin product. The filtrate after crystallization was evaporated and the residue was crystallized from xylenes (0.8 L). Xylenes filtrate was evaporated and the yellowish solid material (65% ± 5% purity of lupeol, 37 g) was obtained after drying at 100°C. Lupeol of 65% ± 5% purity was added to acetone (800 ml) and refluxed until all lupeol dissolves. Temperature of the reaction mixture was then decreased to room temperature and the reaction mixture was kept at room temperature until crystallization was completed (about 12 hrs). After filtration the crystals of lupeol were crystallized again using the same procedure from acetone (150 ml) to give 9.4 g of lupeol (85% purity). The yield of lupeol is 0.47% calculated from starting outer birch bark. Combined acetone mother liqueurs were evaporated. Yellow solid (27.6 g) product (50% of lupeol) was obtained and can be used for lupeol separation in recycling process.
Example 9: Betulinic acid separation and purification Dry black solid product from step 1 (196 g) was stined in 3.5 L of water and filtered. This operation was repeated two times using 1 L of water each time. A solution of 2% HCl (0.8 L) was then added to a suspension of solid product in 250 ml of water and stined for 0.5 hours, filtered. Solid product was then washed with water (2x200 ml) and dried at 40°C for 5 hours in vacuum drier to give 32 g of crade betulinic acid. Crade betulinic acid (32 g) was dissolved in 0.95 L of refluxed 2- propanol, filtered and evaporated to 300 ml, and left for crystallization at 35°C for 5 hours. Precipitate was filtered at 35°C and dried at 40°C for 5 hours in
vacuum drier to give 17.6 g of crade betulinic acid. Cmde betulinic acid (17.6 g) was refluxed with 500 ml of 2-propanol and filtered. 2-Propanol was evaporated to volume of 170 ml. After crystallization at room temperature white crystals were filtered and 15.5 g of betulinic acid (92 %>+ purity) was obtained. Betulinic acid (15.5 g) was dissolved in 500 ml of refluxed xylenes and a solution of NaOH (5 g) in 10 ml of water was added. This solution was refluxed with a good stining for 1 hour. Xylenes and water (total volume is 90 ml) were removed by azeotropic distillation from reaction mixture. Sodium salt of betulinic acid was filtered on hot filter and dried at 80oC for 3 hours. White solid product was then added into water (50 ml) and a 1% solution (200 ml) of HCl in water was added dropwise, and stined for 0.5 hour, filtered, washed with water (2x50 ml) and dried. 14 g of betulinic acid (98%) purity) was obtained. The yield of betulinic acid from starting outer birch bark was 0.7%.
Example 10: Betulin separation from birch bark extract Raw Material Amount Birch Bark pellets 100 g Xylenes 1065 ml KOH 6.125 g Water 8.75 ml Celite 521 (Aldrich) 20 g Aluminum Oxide (basic) 2.5 g
(A) Extraction
1. Charge a 1 L round-bottomed flask equipped with a magnetic stining bar, N2 inlet and teflon covered thermocouple with 500 mL of xylenes, and heat the xylenes to 60°C.
2. Charge 100 g of birch bark pellets, continue stirring and heat to 120°C (+/-) 10°C.
3. Keep the mixture stined and heated at 120°C (+/-) 10°C for 2 hours.
4. Filter the hot extraction mixture through a 150 mL fine porosity glass frit (pre- washed with hot xylenes). The birch bark was then returned to the
reaction vessel, and was heated with another 450 mL of xylenes at 120°C (+/-) 10°C for ca. 30 min. The batch was filtered through the same filter funnel. 5. The combined xylene extract was re-heated at 100°C(+/-) 10°C, and was assayed by HPLC (about 4 drops of xylene solution in 1 ml of MeOH). At this point in the process the HPLC assay showed 3.03A% betulinic acid, 88.87A% betulin, 1.53A% lupeol. HPLC conditions: LiChroCart-Purosphere Star Rp-8e (5 μ) 4.6 x 150 mm column at 23°C, linear gradient elution of CH3CN:H2O from 60:40 to 95:5: in 12 minutes (the water and CH3CN each contain 0.25 mL of TFA per liter), hold 95:5 for 5 minutes, flow 1.0 mL/min, ELSD detection (tube at 100°C, gas flow at 2.2 SLPM, 18 psig). Betulinic acid Rt 8.5 min, betulin Rt 9.0 min, lupeol Rt 16.8 min. (B) Purification
1. Prepare a solution of 6.125 g of KOH in 8.75 mL of water.
2. Add drop wise the prepared solution of KOH in water to the birch bark extract in xylenes at 90°C (+/-) 10°C with vigoras stining. Heat to 120°C(+/-10°C). 3. Keep vigorous stirring at 120°C(+/-)10°C and provide azeotropic water distillation (8.75 mL of water should be removed) by refluxing xylenes.
4. About 470 mL of xylene was removed after azeotropic water removal. Do not stop stining during the process of solvent removal.
5. Filter the hot extraction mixture tlirough a pad of celite 521 (ca. 10 g) on a 60 mL medium porosity glass frit (pre washed with hot xylene).
6. Wash the celite pad with 65 mL of 100°C(+/-10°C) xylene.
7. Keep the KOH treated xylene extract (slightly yellow solution) stined at 100°C (+/- 10°C).
8. Add 2.5 g of aluminum oxide (Acros catalog # 18999, activated, basic), and continue stining at 100°C (+/-10°C) for 1 hour.
9. Filter the hot xylene extraction mixture through a pad of celite 521 (ca. 10 g g) on a 60 mL medium porosity glass frit (pre washed with hot xylenes).
10. Wash the celite pad with 10 mL of xylenes at 100°C (+/-10°C).
(C) Isolation
1. Remove ca. 250 mL of xylenes by atmospheric distillation. 2. Cool the batch (about 250 mL) down to 0-5°C and then isolate the product by filtering the solid white precipitate of betulin.
3. Wash the cake with 2 x 20 mL of cold (0-5°C) xylenes.
4. Dry the product for 18 hours in a vacuum oven at 65°C to afford 8.46 g of betulin (8.46% yield). 5. The product assayed at this point by HPLC showed no detectable betulinic acid, 99.64A% betulin, 0.09% lupeol. Assay for floe using the sarcosinate method showed a clear solution.
Example 11: Analytical Testing of Purified Sample
The following was performed by J-Star Research, Inc. (South Plainfield, New Jersey) and Regis Technologies, Inc. (Morton Grove, Illinois). The validation protocol for a High Performance Liquid Chromatography (HPLC) assay for Betulinic Acid impurity in Betulin tests the accuracy, precision, linearity, sensitivity, range and specificity. To asses the suitability of the method for detection of Betulinic Acid in Betulin, the following conditions were selected for use with the HPLC:
Column: Merck Purospher STAR RP-8, 250 mm x 4.0 mm, 5 micron
Mobile Phase: A= 0.02% Trifluoroacetic acid (TFA) in water, B= 0.02% TFA in Acetonitrile (CAN)
Flow Rate: 1 mL/min Profile: Gradient (see Table 1 below) Column Temp: 40°C Ultra Violet (UV) Detection: 205 nm
Concentration: 50 mg/mL Injection Volume: 5 μL Needle Wash: Tetrahydrofuran (THF) Stop Time: 30 minutes (Post Time = 0 minutes).
Table 1 : Pump Gradient Program
The approximate expected retention time for Betulinic Acid is 7.7 minutes. Specificity is determined by an analysis of the diluent blank sample. Specificity of the instrument is acceptable when there is no interference of the blank sample with quantitation of the target sample. In order to test the linearity of the relationship between the target sample and concentration, five standards are prepared covering the range of 10-120% of the 50 μg/mL target concentration for Betulinic Acid. The peak area response versus concentration is evaluated by linear regression. The slope, intercept and residual sum of squares are reported to provide a linear conelation of not less than 0.99 (1 being perfectly linear). The sensitivity samples have target concentrations of 12.5 μg/mL and 5 μg/mL Betulinic Acid. These concentrations conespond to 25%> and 10% of the target Betulinic Acid concentration and also to 0.025%) and 0.01% impurity in Betulin, respectively. The sensitivity is then evaluated on the detection and recovery (60-140%) of these sample concentrations. Precision of the system is confirmed by the testing of six repeatable samples. Six samples are prepared consisting of Betulinic Acid at 50 μg/mL in diluent or 100% of the target concentration. An additional six samples of 50
μg/mL Betulinic Acid in Betulin are prepared as spiked samples. The second set of samples represents the 0.1% impurity in Betulin. To attain acceptable precision, the relative standard deviation of the sample sets should not exceed 10%. The range of the analytical method is simply evaluated on the acceptable degree of linearity, precision and accuracy for the major sample peak. Accuracy is infened based on acceptable results for specificity, linearity and precision. To confirm sample stability, samples of the target concentration of Betulinic Acid (50 μg/mL) in diluent and spiked Betulinic Acid (50 μg/mL) in Betulin are tested over a 48-hour time period. The response variation should not exceed a 10%) relative standard deviation. All publications, patents, and patent documents are incorporated by reference herein, as though individually incorporated by reference. The invention has been described with reference to various specific and prefened embodiments and teclmiques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention.
Claims
1. A method for obtaining a natural product from plant material, the method comprising: (a) contacting plant material with a solvent to provide a first mixture; (b) separating the plant material from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in a solvent that: (i) is water-immiscible,
(ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C; effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; (f) contacting the fourth mixture with a binder, thereby providing a fifth mixture; (g) concentrating the fifth mixture, or precipitating solids from the fifth mixture, to provide a natural product.
2. The method of claim 1 wherein more than one natural product is obtained.
3. The method of claim 1 wherein at least one of betulin, betulinic acid, and lupeol are obtained.
4. The method of claim 1 wherein the natural product obtained is betulin, in a purity of at least about 95 wt.%.
5. The method of claim 1 wherein the natural product obtained is betulin, and wherein the betulin includes betulinic acid in a weight ratio of at least about
5,000:1, of betulm to betulinic acid.
6. The method of claim 1 wherein the natural product obtained is betulin, and wherein the betulin includes betulinic acid in a weight ratio of at least about 10,000:1, of betulm to betulinic acid.
7. The method of claim 1 wherein the natural product obtained is betulin, and wherein the betulin includes betulinic acid in an amount of up to about 0.02 mol. %.
8. The method of claim 1 wherein the precipitating of the solids from the fourth mixture provides the natural product and a mother liquor.
9. The method of claim 1 wherein the precipitating of the solids from the fourth mixture provides betulin, and a mother liquor that comprises lupeol.
10. The method of claim 1 wherein, in step (e), the solids separated from the third mixture comprise betulinic acid.
11. The method of claim 1 wherein the plant material employed comprises birch bark.
12. The method of claim 1 wherein the plant material employed comprises inner birch bark.
13. The method of claim 1 wherein the plant material employed comprises outer birch bark.
14. The method of claim 1 wherein the plant material employed comprises birch bark pellets.
15. The method of claim 1 wherein the plant material employed comprises at least about 150 kg of birch bark.
16. The method of claim 1 wherein the plant material employed comprises at least about 2,000 kg of birch bark.
17. The method of claim 1 wherein the plant material employed comprises Betula papyrifera, Betula pendula, or a combination thereof.
18. The method of claim 1 wherein the plant material employed comprises Tanzanian Tree Uapaca nitida MuU-Arg (Euphorbiacea), leaves and/or bark of Bacopa monniera (West Bengal), Dilleniacea (Acrotrema arnothianum Wight), Dillenia andamanica Parkinson, D. aurea Smith, D. bracteata Wight, D. indica Linn, D. pentagina Roxb, D. retusa Thunb, D. scabtalla (D. Don) Roxb, exWall, Tetracera (Houtt. exChrism.& Panz., Men.), Tetracera akara (Burm.f.) Men., T. indica (Houtt. exChrism.& Panz., Men.), T. sarmentosa (L.) Vahl. Subsp. Andamanica (Hoogl.) Hoogl., T. scandens (L.) Men, or any combination thereof.
19. The method of claim 1 wherein the solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C, in step (d) comprises an optionally substituted aromatic hydrocarbon.
20. The method of claim 1 wherein the solvent that: (i) is water-immiscible, (ii) is capable of fomiing an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C, in step (d) comprises at least one of xylene, toluene, and benzene.
21. The method of claim 1 wherein the contacting in step (a) is further accompanied by heating the first mixture.
22. The method of claim 1 wherein the contacting in step (a) is further accompanied by heating the first mixture above about 90°C.
23. The method of claim 1 wherein the contacting in step (a) is further accompanied by heating the first mixture to reflux.
24. The method of claim 1 wherein the contacting in step (a) is further accompanied by heating the first mixture for more than about 30 minutes.
25. The method of claim 1 wherein the separating in step (b) includes filtering the first mixture, decanting the first mixture, or a combination thereof.
26. The method of claim 1 wherein the separating in step (b) comprises filtering the first mixture, decanting the first mixture, or a combination thereof; wherein the temperature of the first mixture is above about 70°C.
27. The method of claim 1 wherein the separating in step (b) comprises filtering the first mixture, decanting the first mixture, or a combination thereof; and washing any solids obtained with a water-immiscible solvent.
28. The method of claim 1 wherein the separating in step (b) comprises filtering the first mixture, decanting the first mixture, or a combination thereof; and washing any solids obtained with a water-immiscible solvent having a temperature of up to about 110°C.
29. The method of claim 1 wherein the separating in step (b) comprises filtering the first mixture, decanting the first mixture, or a combination thereof; and washing any solids obtained with xylenes.
30. The method of claim 1 further comprising, after step (b), concentrating the first extract.
31. The method of claim 1 wherein the aqueous base comprises an alkaline metal or an alkaline earth metal.
32. The method of claim 1 wherein the aqueous base comprises a lithium ion (Li+), a sodium ion (Na+), a potassium ion (K+), a calcium ion (Ca2+), a barium ion (Ba+), an alkyl ammonium ion (R1R2R3R4N+), wherein each of R!-R4 is independently (Cι-C20) alkyl, optionally substituted with one or more of halo, cyano, nitro, alkoxy, amino, or trihaloalkyl; or any combination thereof.
33. The method of claim 1 wherein the aqueous base comprises at least one sodium hydroxide (NaOH) and potassium hydroxide (KOH).
34. The method of claim 1 wherein, in step (d), the second mixture is heated at a temperature and for a period of time, effective to distill off water present in the second mixture and to hydrolyze natural esters of the natural product.
35. The method of claim 1 wherein, in step (d), the second mixture is heated to reflux.
36. The method of claim 1 wherein, in step (d), the water is distilled off azeotropically with the water-immiscible solvent.
37. The method of claim 1 wherein, in step (d), up to about 100 wt.% of the water is azeotropically distilled off.
38. The method of claim 1 wherein, in step (d), more than about 95 wt.% of the water is azeotropically distilled off.
39. The method of claim 1 wherein, in step (d), the heating is further accompanied by agitating the second mixture.
40. The method of claim 1 wherein, in step (d), the heating is further accompanied by vigorously stining the second mixture.
41. The method of claim 1 wherein the solvent in step (a) is water-miscible, and the water-miscible solvent is subsequently removed, prior to the heating in step (d).
42. The method of claim 1 wherein the solvent in step (a) is water- immiscible, and the water-immiscible solvent is present during the heating, in step (d).
43. The method in claim 1 wherein the separating comprises filtering, decanting, or a combination thereof.
44. The method in claim 1 wherein, in step (e), the solids that are separated from the third mixture comprise betulinic acid.
45. The method of claim 1 wherein the separating in step (e) includes filtering the third mixture, decanting the third mixture, or a combination thereof.
46. The method of claim 1 wherein the separating in step (e) includes filtering the third mixture, decanting the third mixture, or a combination thereof; wherein the temperature of the third mixture is above about 70°C.
47. The method of claim 1 wherein the separating in step (e) includes filtering the third mixture, decanting the third mixture, or a combination thereof; and washing any solids obtained with a water-immiscible solvent.
48. The method of claim 1 wherein the separating in step (e) includes filtering the third mixture, decanting the third mixture, or a combination thereof; and washing any solids obtained with a water-immiscible solvent having a temperature of up to about 110°C.
49. The method of claim 1 wherein the separating in step (e) includes filtering the third mixture, decanting the third mixture, or a combination thereof; and washing any solids obtained with xylenes.
50. The method of claim 1 wherein the fourth mixture comprises a binder selected from the group of metal hydrides, metal alcoholates, ortho-esters and dialkoxysulfates, and combinations thereof
51. The method of claim 1 wherein the fourth mixture comprises a binder selected from the group of lithium hydride (LiH), sodium hydride (NaH), potassium hydride (KH), calcium hydride (CaH2), and lithium aluminum hydride (LiAffi ).
52. The method of claim 1 wherein the fourth mixture comprises a binder selected from the group of sodium methoxide (NaOMe), sodium ethoxide (NaOEt), potassium methoxide (KOMe), potassium ethoxide (KOEt), aluminum wo-propoxide [Al(i-PrO)3], aluminum tert-butoxide [Al(t-BuO)3], aluminum ethoxide (Al(OEt)3), aluminum propoxide (Al(OPr)3, aluminum butoxide (Al(OBu)3), and aluminum methoxide [Al(OMe)3].
53. The method of claim 1 wherein the fourth mixture comprises a binder selected from the group of ethylorthocarbonate, dimethylsulfate, and diethylsulfate.
54. The method of claim 1 wherein, in step (f), the concentrating of the fourth mixture is canied out at a pressure of up to about 1 atm.
55. The method of claim 1 wherein the amount of natural product obtained, based on the amount of the first extract obtained in step (b), is at least about 65 wt.%.
56. The method of claim 1 that provides about 40 wt.% to about 65 wt.% of betulin, based upon the amount of concentrated first extract.
57. The method of claim 1 that provides about 10 wt.%) to about 25 wt.% of betulin, based upon the amount of the plant material employed.
58. The method of claim 1 that provides about 2 wt.% to about 5 wt.% of lupeol, based upon the amount of concentrated first extract.
59. The method of claim 1 that provides about 2 wt.% to about 5 wt.% of betulinic acid, based upon the amount of concentrated first extract.
60. A method for obtaining betulin from birch bark, the method comprising: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C; effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; and (f) concentrating the fourth mixture to provide betulin, or precipitating betulin from the fourth mixture.
61. A method for obtaining lupeol from birch bark, the method comprising: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in a solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C; effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture to provide a fourth mixture; (f) contacting the fourth mixture with a binder to provide a fifth mixture; (g) concentrating the fifth mixture, or precipitating solids from the fifth mixture; (h) filtering any solids from the fifth mixture to provide a mother liquor; (i) concentrating the mother liquor to provide crade lupeol; (j) washing the crade lupeol with a polar organic solvent; (k) recrystallizing the crade lupeol from a non-polar organic solvent; and (1) recrystallizing the crade lupeol from a polar organic solvent.
62. The method of claim 61, wherein the polar organic solvent in (j) comprises acetone, methyl ethyl ketone, ethyl acetate, or any combination thereof.
63. The method of claim 61 , wherein the non-polar organic solvent in (k) comprises cyclohexane, hexane, heptane, hexanes, toluene, benzene, p-xylene, m-xylene, o-xylene, trifluoromethylbenzene, or any combination thereof.
64. The method of claim 61, wherein the polar organic solvent in (1) comprises acetone, methyl ethyl ketone (MEK), ethyl acetate, methanol, ethanol, or any combination thereof.
65. A method for obtaining betulinic acid from birch bark, the method comprising: (a) contacting birch bark with a solvent to provide a first mixture; (b) separating the birch bark from the solvent to provide a first extract; (c) contacting the first extract with an aqueous base to provide a second mixture; (d) heating the second mixture in a solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C; effective to distill off water present in the second mixture, thereby providing a third mixture; (e) separating solids from the third mixture; (f) washing the solids with water; (g) neutralizing or acidifying the solids in an aqueous acid, thereby providing a fourth mixture; (h) separating betulinic acid from the fourth mixture; (i) crystallizing the betulinic acid with a polar organic solvent; and (j) optionally drying the betulinic acid.
66. The method of claim 65, wherein the acid in (g) comprises H2SQ4, HCl, H3P04, HNO3, HNO2, H3P03, CH3COOH, CF3COOH, H3S03, or any combination thereof.
67. The method of claim 65, wherein the polar organic solvent in (i) comprises CH3OH, EtOH, PrOH, i-PrOH, BuOH, t-BuOH, sec-BuOH, C5HπOH, acetone, ethyl acetate, methylethyl ketone (MEK), diethyl ketone, or any combination thereof.
68. A method for purifying an extract of a natural product, the method comprising: (i) contacting an extract of a natural product with an aqueous base, to provide a first mixture; (ii) heating the first mixture in a solvent that: (i) is water-immiscible, (ii) is capable of forming an azeotropic mixture with water, or (iii) has a boiling point of at least 100°C; effective to distill off water present in the first mixture, thereby providing a second mixture; (iii) separating solids from the second mixture, to provide a third mixture; and (iv) concentrating the third mixture or precipitating solids from the third mixture, to provide a purified natural product.
69. The compound obtained from the method of any one of claims 1 -68.
70. A pharmaceutical composition comprising a pharmaceutically acceptable canier and the compound of claim 69.
71. A cosmetic composition comprising a cosmetically acceptable carrier and the compound of claim 69.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51898803P | 2003-11-10 | 2003-11-10 | |
| PCT/US2004/038252 WO2005047304A2 (en) | 2003-11-10 | 2004-11-10 | Method for obtaining natural products from plant material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1687326A2 true EP1687326A2 (en) | 2006-08-09 |
Family
ID=34590334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP04811101A Withdrawn EP1687326A2 (en) | 2003-11-10 | 2004-11-10 | Method for obtaining natural products from plant material |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1687326A2 (en) |
| WO (1) | WO2005047304A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4186575A1 (en) | 2021-11-30 | 2023-05-31 | Raiz - Instituto De Investigação Da Floresta E Papel | Integrated process for extracting bioactive compounds from eucalyptus biomass |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2649144A1 (en) * | 2006-04-13 | 2007-10-25 | Regents Of The University Of Minnesota | Therapeutic triterpenoids |
| RU2322091C1 (en) * | 2006-08-01 | 2008-04-20 | Общество с ограниченной ответственностью "Березовый мир" | Composition of biologically active substances and method for preparing its nanodispersion |
| RU2354147C2 (en) * | 2006-12-27 | 2009-05-10 | Общество с ограниченной ответственностью "Химико-биологическое объединение при РАН "Фирма ВИТА" | Method for making active admixture to makeup preparations |
| PT106278B (en) | 2012-04-26 | 2018-01-03 | Raiz Inst De Investigação Da Floresta E Papel | METHOD FOR OBTAINING A RICH EXTRACT IN TRITERPENIC ACIDS FROM EUCALYPTUS SHELL |
| WO2014158685A2 (en) * | 2013-03-14 | 2014-10-02 | Avon Products, Inc | Tetracera asiatica extracts and methods of use |
| FI125475B (en) | 2013-08-19 | 2015-10-15 | Separation Res Ab Oy | Method of hydrophobization and substrate |
| CN107019660B (en) | 2017-04-27 | 2018-05-11 | 养生堂(上海)化妆品研发有限公司 | Moisture-keeping cosmetics composition |
| CN107603555A (en) * | 2017-10-17 | 2018-01-19 | 高俊 | A kind of preparation method of mould proof clean type glass cement |
| EP4007587A4 (en) * | 2019-08-02 | 2023-09-27 | Oy Granula AB LTD | METHOD AND COMPOUND FOR PREVENTING CANCER CELL PROLIFERATION IN MAMMALS AND FOR TREATING CANCER |
| CN116573970B (en) * | 2023-07-12 | 2023-09-22 | 云南省农业科学院农业环境资源研究所 | Compositions containing Burkholderia and their use in plant diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1063118A (en) * | 1964-12-01 | 1967-03-30 | Roger Bellon | Plant extract |
| FR2802818B1 (en) * | 1999-12-24 | 2002-08-30 | Greentech Sa | PROCESS FOR OBTAINING BIRCH BARK EXTRACT, BETULA ALBA, AND RELATED SPECIES |
| WO2002026343A2 (en) * | 2000-09-29 | 2002-04-04 | Regents Of The University Of Minnesota | Process for extracting compounds from plants |
-
2004
- 2004-11-10 EP EP04811101A patent/EP1687326A2/en not_active Withdrawn
- 2004-11-10 WO PCT/US2004/038252 patent/WO2005047304A2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2005047304A3 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4186575A1 (en) | 2021-11-30 | 2023-05-31 | Raiz - Instituto De Investigação Da Floresta E Papel | Integrated process for extracting bioactive compounds from eucalyptus biomass |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005047304A2 (en) | 2005-05-26 |
| WO2005047304A3 (en) | 2005-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Szopa et al. | Current knowledge of Schisandra chinensis (Turcz.) Baill.(Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies | |
| EP1355708B1 (en) | Process for extracting compounds from plants | |
| US20020155177A1 (en) | Process for extracting compounds from plants | |
| CA2235565C (en) | Process for the preparation of rhus verniciflua extract and anti-cancer composition containing same | |
| Pujari et al. | Antidiabetic activity of Physagulin-F isolated from Physalis angulata fruits | |
| Grace et al. | Antiplasmodial activity of the ethnobotanical plant Cassia fistula | |
| Topçu et al. | Bioactive constituents of Anatolian Salvia species | |
| WO2005047304A2 (en) | Method for obtaining natural products from plant material | |
| Kumar et al. | Himalayan (Himachal region) cedar wood (Cedrus deodara: Pinaceae) essential oil, its processing, ingredients and uses: A review | |
| US20080058273A1 (en) | Compound Extracted from Husk and Fruit Stem of Xanthoceras Sobifolia and Its Extracting Method and Use Thereof | |
| WO2011064710A1 (en) | In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives | |
| Abdollahnezhad et al. | Purification, characterization, and antioxidant activity of daucosterol and stigmasterol from Prangos ferulacea | |
| Famojuro et al. | Anti-sickling activities of two isolated compounds from the root of Combretum racemosum P. beauv.(Combretaceae) | |
| Kwekowe et al. | Isolation and characterization of secondary metabolite from the stem bark extract of Allophylus africanus Beauv (Sapindaceae) | |
| Rajalakshmi et al. | Pharmacognostic evaluation of Abies webbiana leaf: a Siddha herbal ingredient | |
| Rajani | Phytochemical screening, GC-MS analysis of Decalepis hamiltonii Wight & Arn. An endangered medicinal plant | |
| RU2139722C1 (en) | Agent "silibokhol" used for treatment of patients with hepatitis and method of its preparing | |
| WO2001090064A2 (en) | COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE | |
| Forman et al. | Quantification of some secondary metabolites in selected Cornaceae species/Stanovenie vybraných sekundárnych metabolitov v niektorých druhoch čeľade Cornaceae | |
| Akkiraju et al. | Phytochemical analysis and HPLC study of vitamin-C from Punica granatum L. Aarakta variety of India | |
| Sindhuja | Phytochemical Compounds from the Ethanolic Extract of Gymnema sylvestre, Senna auriculata and Cissus quadrangularis through GC-MS Analysis | |
| Ogwuda et al. | Phytochemical screening and chemical analysis of cloves (Syzygium Aromaticum) flower buds | |
| Shamsudin et al. | LC-MS QTOF analysis of phytochemical constituents in aqueous and ethanolic leaf extract of Azadirachta indica | |
| EP1715879A1 (en) | Onion extracts | |
| Yadessa et al. | Antibacterial triterpenoid from the leaves extract of Ehretia cymosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20060609 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20070601 |